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ABSTRACT
Abstract of the dissertation entitled ''Isolation of a Cationic
Blood Protein with lns.ul in-like Activity" submitted by Harald L.
Guenther in partial fulfillment of the requ\rements for the degree
of Doctor of Philosophy, F~bruary, 1974.
This dissertation is concerned with the goal of re-investigating
the validity regarding the conflicting reports that substances other
than insulin itself which exhibit insulin-like activity are found in
human plasma.

The principal objective was to determine whether

insulin, when it circulates in blood, does so as cationic proteininsulin complex.

Since the finding of Antoniades and coworkers in

1958, in which they reported on the isolation of a protein-bound
insulin, could not be reproduced, a new experimental procedure
was worked out to isolate this compound.
Human serum or plasma were obtained from the Clinical Chemical
Laboratories of the Foster G. McGaw Hospital of Loyola University
of Chicago.

Since blood was collected from numerous patients, the

product derived from it represented a good cross-section of human
serum.
Pre-determined amounts of serum were mixed with a definite
portion of Sephadex C-50, Amberl ite IRC 50 and BioRad Rex 63.

High

pH and/or high concentration of salts were avoided as required
when attempting the elution of cationic proteins from Dowex 50 but

iv
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not with the much weaker exchange resins used in this project.

An

ammonium carbonate. gradient ranging in concentration from 0.005 M
to 1.0 M was used at pH 7.8.

The elution protein peaks were assayed

for insulin activity with the rat diaphragm assay using heparin
and biotin as possible activators in concentrations of O. lmg/ml and
Concentrations of 200

O.Olmg/ml respectively.

.!. 55, 175 .!. 70

and

117 .!. 30 insulin equivalents/ml of plasma were calculated from
Sephadex, Amberl ite and BioRad respectively, in ·the case of heparin
and values of 310 .!.. 65, 298 .!.. 47 and 217

.!. 67 in the ·case of biotin.

lmmunoreactable insulin (LRL) was detected with the radioimmunoassay as fo I lows~

115 .!. 20 uU/m r, in the case of Sephadex, 107 +

30 uU/ml for Amberlite and 89· .!.. 17 uU/ml serum in the case of
BioRad 63 when heparin was used.

Biotin did not promote the release

of any appreciable amount of LKL.

When the insulin-protein fraction

was assayed in increasing amounts, a definite slope with the Randle
and

~ales

plot, was achieved showing that an equilibrium exists

between the

11

free 11 and

11

bound 11 forms of insulin.

Further purification

of the insulin-protein complex (LPC} resulted in two'fractions with
. approximate molecular weights of 158,ooo and 100,000.

The latter

compound exhibited activity in the radioimmunoassay, whereas the other
with the higher

molec~lar

assay as weH,,,as with

weight did not.

the~

With the in vitr6 diaphragm

vivo intraperitoneal bioassay both

fractions showed insulin-like activity indicating that the compound
with the higher molecular weight falls in the category of compounds

v

j

isolated by Froesch and

coworker~.

Experiments i.n which tolbutamide was used to activate the IPC
did not result in insulin activity despite earlier reports in the
literature to the contrary.
Since lysozyme, a strong basic protein, is eluted from the
cationic exchange resin with the fraction containing the IPC, tests
were performed which showed that it did not represent the basic
protein to which insulJn might be bound.

Finally, comparative

studies to isolate lPC from different species such as from plasma
of dogs,'horses, calves and chickens showed that the insulin-protein
complex may well be unique to hunrans.
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CHAPTER 1
INTRODUCTION
Since the discovery of insulin by Banting and Best in 1921,
there has been a steadily growing interest in the hormone.

This

interest has not only resulted from the attention of practicing
clinicians but has been shared by endocrinologists, physiologists,
biochemists, protein chemists and synthetic organic chemists as
well.

Our knowledge concerning the metabolism of insulin and its

effects on the fates of the major nutrients in the body has advanced rapidly in the

l~st

two decades.

Parallel with the gain

of this knowledge have been increasing attempts to elucidate the
mechanism of insulin action.

As various aspects of our under-

standing of the hormone came to fore so did innumerable
associated with this knowledge.

ques~ions'

The fi.rst understanding of the

chemistry of insulin was given to us with the brilliant achievement
of Sanger Cl} in elucidating the complete amino acid sequence of
insulin.

However, 25 years passed before Hodgkin (2) with the aid

of X-ray crystallography proposed a model of the three-dimensional
structure of insulin.

Before the three-dimensional structure was

known, Katsoyannes and coworkers (3) and Zahn 1 s group (4) had
synthesized the hormone

J.!2. vitro.

One hundred years ago, Langerhans saw the islets of the pancreas

2
for the first time composed of cells which we know secrete insulin.
For a long time these cells were highly mysterious, however, today
they are among the cells most widely studied.

Methods have been

devised to perfuse and isolate these cells, facilitating the study
of their metabolism, insulin biosynthesis and mechanisms of insulin
secretion.

The intermediate steps can now be visualized from

electromicroscopic pictures, on the one hand, and from biochemical
studies, on the other.

It is now possible to correlate the structure

and function and to trace, almost step by step, the enzymatic
·machinery of the cell to the final product, insulin, as it leaves
the cell membrane.

Proinsul in, a precursor of the hormone, has

been discovered and many aspects of its conversion to insulin have
been pub I ished.

The physiological and non-physiological stimuli

for insulin or proinsul in secretion and their regulation are known
and their breakdown is being studied.

An impressive amount of data

have been accumulated and the study of insulin has served as a
model and forerunner for research on many other hormones and proteins.
The study of insulin deficiency, diabetes, has given rise to two
divergent opinions as to the metabolic effects of insulin.

One school

of thought maintains that insulin deficiency decreases glucose
oxidation, while the other maintains that it causes a increase in
gluconeogenesis.

Two tissues, muscle and liver have always been

referred to as insulin effective.

The last decade has, however,

witnessed a great concentration of research on a third tissue,

3

adipose tissue, which has proved to be in the majority of anima,ls
a most important target of insulin action.
obvious that insulin

i~

It has now become

not only a regulator of carbohydrate

metabolism but is a general anabolic hormone and has an effect on
lipid and protein metabolism as profound as it has on carbohydrate
metabo 1 ism.
Until recently it has been thought that glucose was the only
metabolite capable of stimulating both insulin synthesis and secretion at physiological concentration.

However, during the past five

or six years evidence has accumulated that indicates that insulin
secretion is affected by a diverse group

o~

nutrients.

Certain

amino acids (28}, ketone bodies (29}, short chain fatty acids (30),
medium length fatty acids (31), as.well as long chain fatty acids (32)
have all been shown capable of provoking insulin release in different
species under a variety of experimental

conditions~

These findings

demonstrate that in different species unique insulin response mechanisms have

evol~ed

for those substances which constitute the major

energy supply to which the species has adapted.
The Biosynthesis of lnsul in.
While it is st i 11 a matter of controversy or rather of ·persona 1
taste whether to call insulin a polypeptide or a protein it has been
established beyond a doubt, that the biosynthesis of insulin follows
the biosynthetic patterns of proteins and not of peptides.

Certain

\

peptides, as Kleinkauf et al. in 1969 (5) showed, are synthesized

4
directly on a multi-enzyme complex with the built-in information for
the correct amino acid sequence, whereas proteins are synthesized
through the well known interaction of messenger RNA, ribosomes, and
transfer RNA's carr~ing specifi~ amino acids.

That insulin is

synthesized on the ribosomes of the beta cells was shown by Lazarow
and collaborators (6), Lindall et al. in 1963

(?), Lazarow et al.

in 1964 (6), and Bauer et al. in 1968 (8), in the isolated islets
of the goosef ish.
Taylor and Parry, in 1963 (9), and Humbel in 1965 (10), showed
that the biosynthesis is inhibited by puromycin and later Steiner
et al. in 1967 (11). with cycloheximide proved and pointed out that
the site of insulin synthesis is the ribosome.
Since it was established by Sanger (1). that insulin consists
of two polypeptide chains, a shorter A chainwithan intrachain disulfide bridge and a longer B chain, the two being interconnected by
two interchain disulfide bridges, investigators have asked them. selves whether or not insulin is assembled in the same manner as
chymotrypsin.

The conversion of' chymotrypsinogen to chymotrypsin

·is the result of breakage of several peptide bonds to yield a three
chain molecule, the intrachain disulfide bridges of chymotrypsinogen
being thus converted to interchain bridges.

The assumption was

that the assembly of the two insulin chains followed the pattern of
assembly of the three chymotrypsin chains, i.e. that there exists
a single chain precursor, an insulinogen.

Wang and Carpenter in

1965 (12.) attempted' to demonstrate an insulin precursor but were

5
unsuccessful.

Givol et al. in 1965 (13), however, obtained evidence

indicating the existence of a single insulin precursor.

They in-

cubated insulin with qn enzyme preparation from 1 iver, disulfide
interchange enzyme, which is able to speed up the formation of the
correct disulfide bridges in

ribonuclea~e.

Once the correct di-

sulfide bridges are made, the reaction stops because the molecule
is at its favored lowest energy level and becomes thereby resistant
against further enzyme attacks.

Givol used this enzyme on insulin

and hypothesized that if excreted insulin would be at its thermodynamically lowest level it should not be acted upon by the enzyme •

.

His data, however, demonstrated that the disulfide bridges in insulin were split and

11

wrong 11 disulfide bonds were made.

His con-

clusion was that insulin is not in its favored thermodynamic state
and that therefore the assembly of two separate synthesized chains

J.!!. vivo

is unlikely.

Humbel and Chrestfield, in 1965 (14), and

Neuman et al., in· 1969 (15} confirmed Givol 1 s hypothesis.

T,he

final proof for a single chain precursor or, as it is called now,
llproinsul in 11 , came from the work of Steiner and collaborators.
Steiner and Oyer in 1967 (16) found in human islets• cells adenoma
and later in normal rat islet tissue, a protein fraction which
could be interpreted as an insulin precursor by the following criteria:
a.

Cross-reactivity with

guin~a

pig antiserum

agai~st

insulin,

but no biological activity.
b.

Procedures which are known to split insulin into its two constituents chains, do not release the separate insulin chains, but
(

6

minimal quantities of trypsin do.
c.

The fraction is eluted earlier than insulin from a Sephadex
column but after trypsin treatment the elution volume becomes
identical to that of insulin.

~.

Incubation of islet

tis~ue

with labeled amino acids for short

time periods labeled fraction b (as Steiner called it) preferentially, and chasing with unlabeled amino acids, transferred the radioactivity to the insulin fraction.
Steiner and Oyer (16) concluded that their fraction b protein was
the precursor of insulin - a single polypeptide chain beginning
at the N-terminal with the B chain sequence of insulin, terminating with the A chain sequence at the C-terminal.
Proinsulin.has subsequently been demonstrated also in bovine
pancreas by Yip and Lin in 1967 (18), Steiner 1967 (17), Schmidt
and Arens in 1968· (20), and in porcine pancreas by Chance et al.
in 1968 (161} and finally proinsulin was demonstrated in codfish
by Grant and Reid in 1968 (21}.

The converting enzyme(s) which

convert proinsulin is (are) as yet unknown.

Clark et al. in

1969 (22} suggested that most of the newly synthesized proinsulin
is normally secreted after its conversion to insulin.

Yip and

Logothetopoulos in 1969 (23) found proinsulin in calf serum and
Rubenstein et al. in 1968 (24), demonstrated it in human serum
and in urine.

It is important to point out (Shaw and Chance (25))

that. even though proinsulin crossreacts with guinea pig antiserum,
it fails to show any biological activity.

7
Regulation of lnsul in Biosynthesis.
Bauer and Lazarow in 1961 (8), and Humbel and Renold in 1963
(26), were unable to demonstrate a significant stimulatory effect
of high glucose concentrations on insulin biosynthesis in isolated
..
fresh islets .!.!J. vitro. However, Smith et al. in 1964 (27), reported that raising the glucose concentration from 25 to 250 mg per
cent increased biosynthesis in bovine pancreas slices by a factor
of ten.

Parry and Taylor in 1966 (9), extended their observation

and found that mannose also stimulated insulin synthesis whereas
galactose had no effect and mannoheptulose proved to be a very
potent inhibitor of insulin biosynthesis.

During the last few

years a number of compounds besides glucose have been shown to
influence the release of insulin.

Amino acids (28), ketone bodies

(29), short- (30}, medium- (311 and long chain fatty acids (32}
have been shown to stimulate the release of insulin.
Glucose and mannoheptulose both seem to act on the synthesis
and release.

Hormones, such as ACTH and glucagon, stimulate in-

sulin release but do not have any effect on its biosynthesis.
Taylor and Parry in 1967 (33), and Grey and coworkers in 1970
(34}, demonstrated the presence of an inducible gluco-receptor in
the rat islet cells which seems to be responsible for induction of
insulin biosynthesis by glucose.
lnsulin Action.
The effects of insulin can be understood most clearly when one
first considers and enumerates the metabolic abnormalities seen in

8
the pancreatectomized animal or in the most severe form of human
diabetes.

In insulin deficiency, the blood glucose level is ex-

traordinarily high.

The
glucosuria, polyuria and mineral losses
, .

are a direct consequence of the high blood sugar level.
and 1 iver, glycogen is

practic~lly

depleted.

In muscle

The synthesis of

proteins is sharply decreased and amino acids are rapidly transformed to sugar, ketone bodies and urea.

All metabolic deviations

can be restored to normal if insulin is made available.

The search

for a direct effect of insulin upon one or'another of the key
enzymatic reactions is still subject to controversy and debate.
The direct effects on some of these enzymes will be discussed a

u

little later in .this chapter.
On the basis of work l!:!_ vivo and in vitro using non-metabolized
sugars, it was shown that insulin

ha~

a profound effect on the rate

of membrane transport of sugars (35, 36).

Tjis was shown to be

true in particular for glucose in a variety of tissues, namely
skeletal and cardiac muscles, fat cells and fibroblasts (37-41).
The molecular mechanism of sugar transport is still poorly
understood, but it seems reasonable to assume that one is dealing
with a specific carrier molecule in the membrane and that insulin
undoubtedly accelerates the activity of this carrier system (42, 43).
The uptake of glucose mediated by insulin, by its target tissues,
follows in sequential steps:

first, transcapillary passage of the

sugar to the surface of the cell; second, membrane transpassage
into the cell, and third, intracellular conversion of the sugar to
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one of its metabolites.

The first step, the passage of glucose

from the capi l lari·es to the cel 1 is not rate 1 imiting; it occurs by
rapid diffusion and
et al. in 1961 (44).

i~

not accelerated by insulin as shown by Morgan
The second, or transport step, which has been

studied by Morgan et al. (45) and Park et al. (37) is very much insulin dependent.

The third step is the only rate limiting step;

here, the sugar is trapped by the cell.

Morgan (44) showed that

the shuttle of glucose into the cell is reversible, even though insulin dependent, but the conversion of glucose to glucose-6-phosphate, which is independent of insulin, determines the amount of
glucose which is transported into the cell.

The transport of a

sugar across the cell membrane seems to be selective, D-glucose
will be transported whereas L-glucose will not (43).

How the

transport proceeds is still a mystery, mainly because we do not,
a~

yet, understand in detail the exact molecular composition and

arrangement of the eel l membrane.

The view most consonant w.ith its

various functions is that the cell membrane consists of an external
and. internal protein layer, between which is sandwiched a bimolecular
leaflet of ordered lipids, mostly of the phosphol ipid variety.

The

protein layers seem most probably to consist of a precisely arrayed
assembly of catalytic materials, enzymes, coenzymes and modu.lators
of their activity.

It is, therefore, reasonable to assume that

insulin combines in a unique way with a specific molecule in the
membrane, and that such binding with the receptor disturbs the
special arrangement of the membrane in such a manner that the sugar

10
carrier can now operate at full capacity.
Effect of Insulin on

Metab~lism.

The abnorma 1 it i,es in metabo 1 ism due to i nsu 1 in deficiency in
the whole organism are the sum of the contributions of all its individual tissues.

The effect and action of insulin have been

studied and investigated almost exclusively on organisms which
suffer diabetes mell itus or which have been made diabetic with
drugs such as alloxan or streptozotocin (160).

As already men-

tioned elsewhere, insulin acts directly on adipose tissue, muscle
and on liver.

Instead of considering each individual tissue to

discuss its action, an attempt will be made to review the knowledge
as it has been elucidated in carbohydrate metabolism in the liver.
It is widely assumed that insulin controls to a great extent the
metabolic. machinery at the level of enzyme induction (40-57).
(

/

1

Since in liver, no permeability barri er for glucose seems to
be present, the assumption has been made that insulin exerts its
influence on the metabolism of the hepatic cell chiefly by controlling the amount and activity of enzymes present.

In 1 iver, as

in other organs, glycolysis and gluconeogenesis oppose each other
and this is reflected in the opposing functions of key glycolytic
and gluconeogenic enzymes.

The identification of the regulatory

significance of the four key gluconeogenic enzymes (glucose-6-phosphatase, fructose-1, 6-diphosphatase, phosphoenol-pyruvate kinase
and pyruvate c.arboxylase) and of the three glycolytic key enzymes
(glucokinase~

phosphofructokinase and pyruvate kinase) is based on

II

ti'\eoretical grounds and on experimental studies of the behavior
of these enzymes under physiological and pathological conditions

(46-57}.

When enzyme assays are carried out at optimum saturation,

levels of substrates, cofactors, coenzymes and under 1 inear kinetic
conditions, then the specific activities measured represent the
amount of the corresponding enzymes present.

Since these specific

proteins, enzymes, are considered the final expression of gene
activity, it can be assumed that the amount of enzyme present is
an indicator of gene expression.

It has been observed by Weber and

'•

coworkers (Li6-54), that insulin in plasma induces key glycolytic
enzymes and, at the same time, suppresses the gluconeogenic enzymes.
The tv:o enzymes that Weber traced were g 1ucose-6-phosphatase and
pyruvate kinase.

When rats v1ere starved for long periods of time

or rnc:de diabetic the opposite effect v1as observed.
of test animals,

Upon refeedirig

insulin induced a rise in the key glycolytic

enzymes vvhich >vas blocked by inhibitors of protein synthesis such
as actinomycin, puromycin and ethionine.
Do5e response studies demonstrated that the insulin-induced
rise in the activity of glucokinase, phosphofructo kinasa and pyruvate kinase was dose dependent (51).

These results, however, may

have been due to factors such as the nutritional state and not insuJ in levels in plasma.

More direct proof of insulin being an

enzyme inducer was obtained by Weber et al. by injecting anti-insul in serum into the rats before refeeding the animals.

This in-

sured that no biologically active insulin was circulating in the
plasma.

Their results shovJed no increase in the glycolytic enzyme
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level, whereas in rats that received no anti-insulin, an increase
of 3 to 400 per cent in enzyme levels above the starving levels was
observed.
The

integratio~:of

1 iver carbohydrate metabolism by insulin,

acting by controlling enzyme synthesis is a powerful and effective
metabolic control.

However, since protein synthesis and· degradation

requires a number of hours, and sometimes days, for effectiveness,
this mechanism can not account for the rapid hepatic response to
insulin.

The acute action of insulin which may be manifested in

a few minutes probably then does not involve increase in enzyme
activity through modulation of gene expression.

In the acute control

it has been shown that cyclic 3,5 1 -AMP plays a strategic role(139).
I •

~

j
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The State of lnsul in in Plasma.
The methods used for the measurement and evaluation of insulin
in plasma wi 11 be described in the chapter

11

Assays for Blood lnsul in. 11

(p.21).

The various assays used to determine insulin in blood often
give rather divergent results (Table I).

In some of the methods,

different physical treatments of the plasma apparently caused a·
considerable rise in insulin activity, thus raising the question as
to whether activity of plasma insulin might not be due to a conversion from one form to another

~epending

on circumstances both

in vitro or in vivo.
TABLE I
lnsul in or Insulin-Like Activity in Pooled Rat Sera
by Different Bio-Assays.

Experimenta 1
condition
.fed
Fasted for 3 days
Alloxan diabetic

lnsul in or insulin-] ike Actiiity*
Rat diaphragm
Adipose tissue
Immune
intraperitoneal
in vitro
assay
420

479

53

76
31

250
104

18
ll

*Values expressed in microunits per mg of crystalline insulih
equivalent.
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TABLE I I
lnsul in or Insulin-Like Activity in Plasma Samples
·From Normal Human Subjects.
lnsul in or insul in-1 ike activity'~
Adipose tissue
lmmuno
Ra.t diaphragm
intraperitoneal
in vitro
assay

Subject

86
100
81
102

A
B

c
D

36
265

5.9
11. 8
2.0

330
710

19.5

expressed in microunits per mg of crystalline insulin
equivalent.

*V~lues

Table I

Metab. Cl in. Exptl., .!2_:

From Partamin, Raisa and Cahill:
10, 1966.

Table I I From Cahill et al.:

Metab. Cl in. Exptl., .!l= 769, 1964.

These data seem to indicate that insulin may be transported in
plasma partially as free molecules and partially in another form,
perhaps bound in some way to certain plasma proteins.

The pos-

sibility that insulin is bound or transported by a carrier protein,
as it is the case with thyroxin has stimulated a large number of
studies on the subject.

Currently the 1 iterature is very confusing

on this subject; thus various investigators use phrases such as
11

Bound insul in 11 , ''lnsul in-1 ike activity",

11

repressible and non-

repressible 11 as well as "atypical insulin" to descr.ibe insulin which
is not active under physiological conditions and which may be bound
to some

car~ier

molecule.

15

Bound lnsul in.
Studies on

11

bound 11 i nsu 1 in using the rat diaphragm assay have

come almost exclusively from the laboratory of Antoniades and coworkers.

In 1958, Antoniades (58) showed that insul in-1 ike activity

(ILA) could be eluted from a cationic excnange resin, Dowex 50 or
IRC 50, which prior to elution, was mixed with whole blood.

The

elution of the ILA was. achieved by using 0.02 N ammonium hydroxide
(61).

Since crystalline insulin is not adsorbed by the resin, it

was hypothesized that the acidic insulin molecule is bound to a
basic protein which itself is adsorbed to the cationic exchange
resin.

Antoniades and coworkers (59) studied ILA by using acid

ethanol precipitations of plasma.

To prevent coagulation of the

blood, two methods wer.e employed.

The blood was either treated

with acid cit.rate dextros.e (ACD), or passed through a cationic
'

exchange resin to decalcify the samples, and thus 'inhibit coagulation.
The samples preserved by the treatment with ACD retained all the insulin-like activity, whereas the samples treated with the cationic
·.exchange resins lost almost all
adipose tissue bioassay.

acti~ity

as measured by the rat

Antoniades then eluted the resin with

0.02 M NH 0H, because he thought that the ILA may have been bound

4

to the resin.

The resin eluate showed no insulin activity when

assayed using the rat diaphragm bioassay:

however, the resin eluate

showed marked insulin activity when the rat adipose tissue bioassay
was used.

These investigators (60) then prepared a saline extract
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of rat epididymal fat pads and combined it v-lith the resin eluates
(bound insulin) and tested .the mixture with the diaphragm assay;
the resin eluates plus the fat pad extracts showed insulin-like
activity, indicating that the fat pads contained a factor capable
of activating inactive insulin.

In vivo studies by Antoniades

et al., in 1969 (61), have indicated that adipose tissue extracts
(ATE) produce hypoglycemic activity in insulin-sensitive animals
using intravenous or intraperitoneal administrations of partially
purified adipose tissue extracts from rat or bovine fat tissue.
Preliminary studies by Antoniades (60) on the nature of the
possible active factor have shown that it is heat stable and has a
molecular weight below 1,000 (60).

Gundersen and Antoniades in

1960 (62) found that when the resin eluate was dissolved in a
buffer solution of pH 9,8 the resin complex could be dissociated.
Furthermore, they sho ded that, at pH 9,8, the basic protein pre1

cipitated and

11

free'' insulin could be detected !n the supernatant

after centrifugation.

Dialysis, without prior neutralization of

the insulin-protein complex as eluted from the resin column at
pH 10.2, against saline for 24 hours, markedly reduced the insulinlike activity in contrast to dialysis of the
previously been neutralized.

cc~plex

which had

This was interpreted by Antoniades

as an indication that the insulin-protein complex may recombine
slowly at neutral pH.

The studies, conducted by Antoniades et

al. (63-65), which seemed to show that insulin exists in two forms,
a

11

free 11 and a "bound" form, and that the equilibrium is shifted
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toward the

11

free 11 form upon ingestion of a glucose load, were

criticized by a number of investigators.

Antoniades further

postulated that, in some cases of diabetes, one of the main
problems may well be the inability to convert the complex or
11

bound 11 insulin to the

11

free 11 form, leading, therefore, to the

observed deficiency in total insulin activity.

The electro-

phoretic mobility of bound insulin corresponds to that of the
beta and gamma globulins (66, 67).

The molecular weight of the

insulin-basic protein complex is approximately 60,000 accordoing
to its behavior on Sephadex G-75

~nd

G-100 (68).

Antoniades (69)

reported.that bound insulin is not neutralized by insulin antiserum, whereas Shaw and Shuy (70) were able to neutralize bound
insulin when they repeated Antoniades• work.

Berson and Yalow

(71, 72) were, however, unable to demonstrate an increase in
plasma insulin using the/ radioimmunoassay.

The findings of Berson

and '(alow were confirmed by Kipnis et al. (73} and Mead et al. (74).
furthermore, an extensive study by Mead (.75) has failed to confirm
.an effect of adipose tissue extract on the effect of ILA in the
diaphragm assay.

Berson and Yalow (76) dismissed Antoniades

1

work

by stating that he had fallen victim to an artifact of the experimental procedure.

They state:

"Bound insulin has no con-

vincing ~asis and in fact is a phantasy that has i~sidiously
captured the fancy of several investigators 11 •

Berson and coworkers

defend their statement by their failure to demonstrate insulinlike activity with the radioimmunoassay and by their failure to
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combine exogenous 1251-insulin, when injected into experimental
animals, to the proposed basic protein carrier.
II

lnsulin-Like·Activity (tLA).
The observation of M.artin et al.. in 1958 015) and Renold et

al. 1960

(118) that adipose tissue .!J:_'vitro is remarkably sensi·

tive to small amounts of insulin, and therefore suited for the determination of insulin in biologic fluids, opened up a vast and
much disputed field of insulin-like

acti~ity

(ILA) in human serum.

The many difficulties started when it became apparent that antiinsul in serum suppressed only a

~ertain

activity of serum, meaning that one is

amount of the insulin-like
de~ling

with a compound

which behaves like human insulin yet does not crossreact with insulin antiserum.

The serum ILA which was not inhibited by insulin

antibodies was termed
(77).

11

non-suppressible 11 (NSILA) or

11

atypical ILA 11

The fraction of lLA which can be eluted from a cationic ex-

change resin was called

11

suppressible 11 or

11

typical 11 ILA.

insulin which is not adsorbed by the resin is named
(78}.

11

Serum

free 11 insulin

The introduction of the radioimmuno-assay by Berson and

Yalow in 1966 (72) gave investigators a tool to compare the values
of serum lLA obtained with bioassays with those obtained with
immunological techniques.
The measurements of non-suppressible insul in-1 ike activity
(NSILA} are performed with the in vitro diaphragm (158) or adipose
tissue

as~ay.(115).

It should be noted thai the values for serum·
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NSILA,. obtained by the diaphragm technique were reported to be
lower than those measured by the adipose tissue assay (79-81).
The

expl~nation

for.this phenomenon wil.l be described in the

discussion of the adipose tissue bioassay.

The diaphragm just

does not respond equally well to all the compounds of serum
NSILA that are measured by the adipose tissue technique.

Froesch

et al. (82) demonstrated through paper electrophoresis and gel
chromatography on Sephadex G-200 that NSILA of native serum
~epresents

a large molecule with an approximate MW of 150,000, with

electrophoretic properties of an

~lpha2

or beta-golbulin (83, 84).

Fractionation of serum by zone electrophoresis separated adqed
12 51-insulin in the alpha -globulin-albumin region from NSILA
1
which has an electrophoretic mobil·ity of a beta- and gammaglobulin (85).

NSlLA was found also in the albumin-alpha-globulins

a·s well as in the gamma-globulins by several autho.rs working with
electrophoretic techniques (81, 86, 87).

The isoelectric point

of purified NSILA (88) 1 ies betwee.n pH 6.0 and 8.0, \n contrast to
. insulin which has an isoelectric point at pH 4.0.

Modification of

the isolation method for NSILA by several investigators resulted
in many disagreements with respect to recovery and suppressibility
of the extracted NSILA by insulin-antibodies and its persist.ence
after pancreatectomy (84, 86, 89, 90}.

Buergi et al. (82) ex-

tracted NSILA with acid-ethanol from a Cohn fraction of human
1

plasma containing mostly alpha- and beta-globul ins, and estimated
the molecular weight of the biologically active material to be
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6,000 to 10,000 by gel filtration on Sephadex G-75.

When an

acetone powder of human plasma, which contained 80% of the total
human serum NSILA, was extracted by Jakob et al. (89), they
found a NSILA compound with a molecular weight of 45,000.
In a study on the properties of NSILA, Froesch et al. (94)
showed that it had the same effect as did crysta11 ine insulin on
the net gas exchange when measured with the adipose tissue assay.
Incorporation of 14c-g1ucose into fatty acids and its oxidation to
14 co

2 by NSILA is comparable to that by insulin in equivalent

amounts.

However, incorporation of radioactive glucose into

glycogen was not stimulated as much by NSILA as by insulin (90).
Buxtorf, in 1969 (91}, studied the influence of NSILA on protein
synthesis.

His investigations revealed that even though NSILA

appears to act on membrane transport, lipogenesis and 1 ipolysis,
it did not affect protein synthesis in the same way as does
insulin.
lt is interesting to note that the level of NSILA seems to be
the same in normal patients as in patients with disorders of carbohydrate metabolism.

Diabetic subjects, patients in diabetic coma

and patients with beta-islet cell adenoma have similar NSILA levels

(941. Variations of blood sugar, induced .by insulin and glu-

cose in human subjects (92) or by fructose (93) and mannoheptulose (94) do not influence the level of NSILA;

Power (95) sug-

gested that non-suppressible ILA may be a third pancreatic

hor~

'~
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mone.

However, his statement has not been proven, and, in fact,

the origin of NSILA is not known as yet.
All the information which has been. obtained indicates that
NSILA cannot replace insulin as a unique hormone controlling the
metabolic machinery.

The hypothesis that NSILA might play a role

in inflammation, during work or other situations in which local
enhancement of glucose uptake might be necessary is a reasonable
one; however, no clear proof has yet been obtained ( 1 63).
Assays of lnsul in in Blood.
Reviewing the di.fferent methods for the assay of insulin in
blood, Goetz (36) has written:
"So much controversy has arisen from studies employing
current methods for.insulin assay in blood that a fresh
consideration of these methods at this time may have some
value, although the subject has been repeatedly reviewed
by others~"
Perusal of the current literature reveals that a major part pf
what is being written deals with methods of insulin assay, the
results obtained, and the controversies generated by them.·
For example, Yalow and Berson (97) write:
1t is sufficient to note here that the radioimmunoassay, properly performed, measures only insulin and no~
other plasma substances that may exhibit insulin-like ac~
tivity in biological systems."
11

On the other hand, Williams and Wood (98) state:
The biological assays measure the net effect of many
factors, positive and negative, influencing glucose uptake.
Certain advantages would seem to be derived from the inclusion of plasma factors influencing the insulin action
11
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since some of the patients• tissues are similarly affected. 11
The two statements reflect differences in desire as to what is
to be measured by

t~ese

assays.

Methods in vivo.
1.

Hypoglycemic Tests.
Since the accepted criterion of insulin action is a fall in

blood sugar, the first insulin assay methods made use of this fact.
An examp 1e of such a method is that of B,e i ge lman (99), who measured
blood sugar

decrem~nt

1000 microunits.

in mice.

The sensitivity of this method was

Beigelman concluded that this method is neither·

sufficiently sensitive nor sufficiently reproducible to constitute
an effective insulin assay.

Average normal fasting values for

human plasma insulin are about 15-20 microunits per ml, as determined by immunoassay (loo}.

l.t is thus obvious that a method in

vivo such as the one described is unsuitable.
These

J.!l

vivo methods can be made more sensitive, however, by

adrenalectomizing and/or hypophysectomizing the test animal.

These

, procedures are also designed to abolish the effect of hormonal
·antagonists of insulin.

If one makes the animal diabetic with

alloxan, one jncreases the sensitivity of the assay even further.
This sort of assay was described by Bornstein (101).

With a rat

which was hypophysectomized, adrenalectomized and made alloxandiabetic the sensitivity of the test method is to 50-500 microunits
of insulin.

The preparation of such altered test animals is
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difficult, time consuming and expensive and their. mortality is 'high.
2.

The in vivo lntraperitoneal Bioassay.
Rafaelsen (102, 103) found that when small quantities of

insulin, less than 10 milliunits per animal, are injected intraperitoneally, the effects of the hormone are limited to the tissues
immediately surrounding the peritoneal cavity.

In particular the

diaphragm as well as the epididymal fat pads are affected by the
presence of insulin.

In the case of the fat pads, valuable results

can be obtained only if the testis of the test animals are pushed
into the abdominal

c~vity,

and the communication between peritoneal

and scrotal spaces is closed.

This preparation is necessary in

order to insure intraperitoneal location of the epididymal adipose
tissue for good contact with the substances injected.
(~iaphragm}

The muscle

and the adipose tissue \fat pads) are very sensitive

to insulin, for glycogen formation in the diaphragm and incr.eased
lipid synthesis in the adipose tissue.
number of questions.

This assay is open to a

Is the assay sensitive enough to.measure

physiological concentrations of insulin?

Does insulin attach itself

to other muscles such as heart and trapezius muscle or to subscapular
brown or possibly mesenteric fat?
(104) answered these questions.

In 1965, Rafaelsen and coworkers
They showed that neither in brown
I

or mesenteric fat, nor in the heart or trapezius muscle, could any
lncorporation of radioactive glucose l4c(U) be detected.

As it

regards sensitivity, as low as 10 microunits, the use of radioactive
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tracers such as glucose 14c (U) made the assay suitable for small
amounts of insulin.
1969 (106), used

Young, 1967 (105), and Young and coworkers,

th~~

assay to detect changes of insulin effective-

ness on muscle tissue when insulin was injected together with sera
or tissue extracts.

They reported that .tissue extracts did not show

any appreciable decrease which might have been attributed to molecules binding insulin.
The intraperitoneal method to test

insulin~~

thus has the

\

following advantages;

first, it involves the diaphragm, an intact

working muscle; second, serum can be tested with the dilution
usually required for insulin

tests~

vitro; third, it permits the

simultaneous measurement of insulin effects on both muscle and
adipose tissue if needed; and fourth, since the effect of insulin
appears to be only a local one, there is probably little involvement
of factors secreted in response to a systemic disturbance of metabolic homoeostasis.

The test, however, also has a drawback, in

common with other bioassay procedures

conducted~~'

in that

it may become. very imprecise unless optimal conditions, such as
weight of the animals, change of environment, etc., are carefully
controlled.

l
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The in vitro Insulin Bioassays.
l.

Rat and Mouse Diaphragm Assay.
Bioassays

~vitro

employ either whole diaphragm or more

commonly hemi-diaphragm and even quarter diaphragms of mouse or
rat.

In short, the assay is performed as follows:

the tissue is

incubated in physiological buffer solution, such as Krebs-Ringer

(107) or Gey-Gey (108) containing glucose in a water saturated
atmosphere of 5% carbon dioxide in oxygen.

The insulin-sensitive

event on which the assay depends is either glucose uptake or
r

glycogen synthesis.

The glucose uptake, which is.measured according

to Krahl and Park (109), has been abandoned almost completely due
to its insensitivity.

Berson and Yalow (110) have shown that in

the range of 10 to 100 microunits of insulin per ml, the insulin
concentration·must be increased by about 225 per cent to produce
a 1% glucose concentration.

irdu~ed

The formation of glycogen,

and augmented by insulin, is the method by which insulin is measured
cur(ently.

Glucose in the incubation medium is spik~d wlth a known

·amount of glucose 1-14c which will b~ incorporated into the glycogen.
The amount of radioactivity appearing in the glycogen will then be
taken as a parameter for the amount of ·insul.in present in t~e medium:
This test shows a sensitivity of 10 to 500 microunits of insulin as
shown by Moody and Feller (111) in a comparative study of insulinsensitive parameters in the mouse diaphragm.

Moody and Feller

found that insulin sensitivity increases in the following order:
glucose uptake, total radioactivity of.tissue incubated with

!

f
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glucose 14c, chemical determination of glycogen formation and
formation of glycogen from labeled glucose.
the diaphragm

bioass~y

plasma may interfere.

The disadvantage of

is that substances which might be found in
Goetz (112) has listed some, namely,

epinephrine (96), free fatty acids and apparently the B chain
of insulin itself (113).

As 1 ittle as 0.01 microgram of epi-

nephrine, almost completely counteracts the effect of 500 microunits of insulin on rat diaphragm.

In addition to these inter-

fering substances, appreciable degradation of insulin occurs
especially when cut preparations (hemi- or quarter diaphragms) are
used (114).

,Proteolytic enzymes are leached out of the cut

muscle fibers into the medium where they then may hydrolyze the
insulin.
2.

The Adipose Tissue Bioassay.
This bioassay was first introduced in 1958 by Martin and

Renold (115}.

The biochemical principle is that adipose tissue

responds to insulin with an increase in glucose uptake with a
preferential oxidation of the sugar via the hexose-monophosphate
shunt.

The reaction pathway is:

1-14c-Glucose

1- 14c-Glucose-6-phosphate---+ 1- 14 c-

phosphogluconic acid
1- 14c-phosphogluconic acid + NADP_____.
ribulose-5-P.

14 co

2 + NADPH +
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The insulin

sensi~ive

parameters that can be measured are glucose

uptake as measured by Beigelman et al. (116), total gas exchange
reported by Ball et.al. (117), or formation of 14co 2 from 14 c-glucose
as worked out by Renold et al. (70).

As shown by Martin (115) and

Renold (118), the fat pad bioassay exhibits great sensitivity to
insulin, up to 10 microunits.

However, a very disturbing feature

in interpreting the results obtained from the use of this assay is
the question of specificity.

It was first shown by Leonards (119)

that insulin-like activity of normal human serum, as determined
with the fat pad, exhibits a very different behavior from that of
insulin.

Unlike insulin, the activity is not extractable by acid

ethanol and is not .neutralized by insulin anti-serum.

What is

even more striking, the activity exists after total pancreatectomy
/

in the dog.

The nature of the insulin-like factor present in

l

serum, as d_escribed in the introduction, is a factor isolated and
somewhat identified by Froesch and coworkers (120).

It is well

known and established that the fat pad responds to a 'great. many
·substances.

A list of such insulinomimetic agents was published

by Ball and Yungas (121).

A list of biologically active peptides

with insulin-like effects can be found in a review by Minsky (122).
Due to reasons mentioned here it seems obvious that-the fat pad
bioassay in spite of its
is limited in its use.

v~ry

high sensttivity and lack of specificity,
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The Radioimmune Assay for Insulin.
Unlike the bioassays discussed in the foregoing section,
..

which depend on some metabolic response of tissues in vivo or
~vitro,

the radioimmunoassay, developed by Berson and Yalow

(123-125), is based on a chemical reaction in the test tube
between a hormonal antigen and its antibody and exploits the wellknown specificity of immunochemical reactions.

This method has

introduced much needed specificity in the assay of plasma insulin
an~,

for that matter, for other hormones in plasma as well.

The

sensitivity of this method is very high, as little as 2 microunits of insulin per milliliter can be detected (126).

Various

modifications of the original method are in current use (127, 128).
All assays employ competition between 13 11 or 1251-labeled insulin and the unlabeled insulin in the unknown sample for binding
sites on the anti-insulin globulin.

To make an analytical assay

. which can be performed with I ittle effort, the insulin antibody
complex has to be made insoluble.

It is well known that insulin

is a very poor antibody producer.

Among mammals, guinea pigs do

produce rather good insulin antibody tit.ers.
bodies are

monovalent~

in solution.

Since insulin anti-

the antibody-antigen complex will remain

It is therefore necessary to develop the ''double

antibody" method (128, 129) in which the antibody-bound hormone
is precipitated with a second antiserum directed against the
immunoglobulir.is of the anti-hormone serum (thus, for anti-insulin
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serum developed in guinea pigs, an antiserum to guinea pig
globulin is required for the precipitation stage).
to guinea pig globulins is p~oduced in rabbits.

The antiserum

Interference

by complement in the second antibody reaction has been avoided
by the inclusion of chelating agents such as EDTA (130, 131).
The antibody-bound labeled insulin is identified by procedures
which separate free from bound. insulin, and the amount of unlabeled insulin is determined by comparison with a standard curve
which relates the
11

11

ratio of antibody-bound to free insulin 11 to

known hormone con cent rat i on 11 •

T.he greater the quantity of

unlabeled insulin to be assayed, the smaller will be the quantity
of labeled insulin bound to antibody, assuming that the antibody
has the same affinity for both insulins, labeled and unlabeled.
This assumption has been questioned by Arquilla, Ooms and Fen (157).
They·found that the attachment of 1251 to insulin seems to impair
the immunological as well as the biological activity of the hormone.
The immunoassay method offers a great number of advantages
.over the bioassays.

It is not only the high degree of specificity

which makes it so attractive but also the small amount of test
substance required for the test; furthermore it

doe~

not suffer

from complications of interfering substances in plasma.

It is

therefore not surprising that the radioimmunoassay has replaced
the bioassays almost completely.

It has found great acceptance

in clinical laboratories where it has been automated (132, 133).
Results obtained by the radioimmunoassay. fat pad and diaphragm
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bioassays frequently have been compared.

Goetz (96) made a

critical appraisal of the comparisons in which he says:
Comparison between assay results by different methods
obtained in different laboratories, or even in the same
laboratory must be accepted with reservation because of
the lack of precision which has been accepted as the price
of great sensitivity of •these methods 11 •
11

They note that there is apparently very 1 ittle relationship
among the absolute values of insulin in plasma samples assayed
by different methods.

CHAPTER 11
MATERIALS AND METHODS
Radio immunoassay of lnsul in
The radio.immunoassay was carried out using a modification (146)
of the procedure described by Hales and Randle (127).

This assay is

sufficiently sensitive to satisfy research requirements and is well
suited to the prob 1em of hand 1 i ng. 1a rge numbers of samp 1es.
Reagents:
1.

Insulin binding reagent (double antibody} used in all immuno-

assays is prepared by the Wellcome Research Laboratories, Beckenham
K~nt,

England.BR3 3 BS and distribut,ed by Amersham/Searle Corpora-

tion, Arlington Heights, Illinois.

The batch which we used was

labeled as #l<.4908 and had the Catalog number MR48.
The.commercial product is prepared in the following manner!
Antisera are prepared to insulin (in guinea pig) and to guinea
serum proteins (in rabbits).

pi~

After adjusting t.he titer of an

anti-insulin serum, it is diluted in phosphate buffer containing
EDTA (ethylenediamine tetra-acetic acid) and mixed with a predetermined amount of the anti-guinea pig precipitating serum.
The mixture is allowed to react at 4°C for 18

31

hou~s

and tnen

free~e-

'
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dried.

When reconstituted to a volume of 8 ml each vial will

contain precipitated guinea pig serum, diluted 1:16,000 in buffer B
(see buffer preparat_ion) containing _0.03 M EDTA.

This reagent

then will bind approximately 40 per cent of a standard dose of
250 picograms of insulin.
2.

Radio-iodinated Insulin.

1251-insulin was obtained from Amersham/Searle C., Batch #6
Catalog number lM38.

The 12 51-insulin is prepared from specially

purified crystalline ox insulin with a potency.of 24.3 international units per milligram; unbound iodine is removed by gel
filtration.

Each vial contains O.l microgram of 12 51-insulin

dissolved in buffer A (see buffer preparation).
3.

Buffer Solutions.

Buffer A - 40 mM phosphate buffer, pH 7.4, for dilution of antisera and iodinated insulin.
7.0 g sodium phosphate monobasic - monohydrate
(NaH 2 P04 • H20)
1.0 g sodium az i de (NaN )
3
1.0 g polyvinylpyrrolidone (PVP), Matheson-Coleman and
Bell,

~orwood,

Ohio.

Sodium hydroxide, 2 N, to adjust to pH 7.4
Deionized water to 1 liter, pH adjusted to 7.4
Stored at 4°C.

l
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Buffer B - Buffer for dilution of standard insulin and plasma
samples.
9.0 g sodium chloride (NaCl)
Buffer A, to

1 i ter

Stored at 4°C.
Buffer C - Buffer for washing antibodies.
39.0 g PVP
Buffer A to 1 1 iter
Stored at 4°C.
Composition of Scintillation Fluors.
Fluor

150 'ml ethanol (absolute)
300' ~1 p-dioxane (scint111ation grade)

50.g naphthalene (recrystallized)
5 g

2~5-diphenyloxazole

(PPO) Packard, lot #4627

Toluene (scintillation grade, Beckman} to
Fluor

ll

1 i ter

50 g naphthalene

5 g PPO
p-dioxane, to 1 liter
Fluor lll

5 g PPO
liter

Toluene, to
)

All fluors were stored in brown bottles, away from direct light.
Of the three fluors, No. I I l was used exclusively, since the
counting effi'ciency was the same as that obtained with the more complex
fluors I and.) I.

34
Apparatus.
a)

Micropipettes.
Microliter pipettes, Eppendorf or Oxford, were used (size
10

µ

1, 50

µ

l and 100

µ

l).

These pipettes were obtained from

Scientific Products, Chicago, Illinois.
b}

Filtration apparatus.
The filtration of the insulin antibody complex was performed
with the Millipore manifold.

(Sampling Manifold #3025, Catalog

#XX 27 02530 Millipore Company, Bedford, Massachusetts).
c} · Fl l ters.
Due to their uniformity, Gelman filter discs were used rather
than the commonly used Millipore filters.

(Gelman Instrument

Company, Ann Arbor, Michigan).
d)

Test tubes.
Micro-test tubes (5 x 50 mm) Kimax, available from Scientific
Products, proved to be very suitable for the experiments.

e)

Liquid scintillation.
The radioactivity of the insulin antibody complex was measured
with a Beckman Liquid Scintillation Spectrometer, Model LS-250.

Assay Procedure. ·
Volumes of 0.1 ml of insulin binding reagent were dispensed
I

into 5 x 50 mm culture tubes, which were kept cold in an ice bath.
The binding reagent which comes in powdered form was re·constituted

L
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to 1 vial of powdered reagent, 8 ml of deionized

as follows:

water was added carefully and mixed gently to avoid foaming.
Aliquots of 0.1 ml of the unlabeled insulin standards (see
preparation of insulin standards), unknown solutions, or blanks
consisting of buffer B were added to the culture tubes containing
the binding reagent.

The tubes were then mixed In a Vortex Jr.

Mixer and placed in the refrigerator for 6 hours at 4°C.
After 6 hours, the tubes were removed from the refrigerator
·and returned to the ice bath and O. 1 ml of the prepared 1251-iodinated insulin solution was added to the tubes.
tion was prepared in the following manner:

This working solu-

1.0 ml of the commer-

cially available radioactive insulin (Amersham/Searle) was withdrawn from the ampule with a syringe and carefully added to 7.0 ml
of buffer B.

After the working solution of 12 51-insulin was made

the mixture was mixed and then returned to the refrigerator for
18 hours.

The final composition of a representative series of

tubes is given in Table IV.

At the end of 18 hours, the tubes

were removed from the refrigerator and placed in ·the ice bath for
processing.

A micro-analysis filtration apparatus was used to

collect the precipitated insulin antibody complax.

Prior to the

start of the assay, the membrane filter discs (Gelman) were presoaked in cold buffer C for at least 24 hours.

The filter discs

were then applied to the filter holders using forceps and the
apparatus was connected to a vacuum of approximately 14mm Hg.
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With the aid of Pasteur pipettes, the contents of the culture
tubes were carefully applied to the filter discs.
was then washed twic·e with 1.0 ml of cold buffer C.

Each filter
The purpose

of these washings was to remove unbound radioactive insulin.
The filters were then removed from the manifold with forceps and
placed immediately into appropriate counting vials.

After all

the samples had been processed in this manner, the counting vials
were placed for 15 minutes in a drying oven preheated to ll0°C.
Once the scintillation vials were cooled to room temperature
10.0 ml of scintillation fluor lll was added.

The filter discs

have to be absolutely dry before the fluor can be added.

The

filters will become transparent once the fluor is added; if
moisture remains in the filter material, they will not become
transpacent and the measure.ment of the radioactivity will be
impaired.
The samples were then placed in a Beckman LS-250 liquid
scintillation counter and allowed to dark-adapt for 2 hours.

In

all cases_, the vials were counted for 10 minutes, in three cycles.
The third count, in almost all instances was used for the data
evaluation.
The gain control was set at 360 and the full window isoset
was employed to obtain maximum efficiency in the counting.

The

external standard ratio system of the instrument was employed to

1..
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monitor the relative quenching of the samples and to determine
whether or not corrections for quenching would have to be applied
to the results.

The external standard ratio (ESR) reading reflects

the efficiency of the count for each individual sample.

If there

is a considerable variation in ,the external standard ratios of
the individual samples, then a correction factor must be appl led
to the raw results of the counts to compensate for a varying
efficiency in counting of different samples.

If the ESR readings,

however, .are uniform, then this reflects the fact that the efficiency
of the counts is uniform enough to make any correction factor unnecessary.
~espect

to the external standard, thus no quenching correction was

necessary.
count.

It was found that the samples were very uniform with

One set of replicates was prepared to obtain a control

These tubes were the wash control samples; only iodinated

irisutin and buffer were placed in th~ culture tube~

They reflected

the degree of retention of the free labeled insulin by the filter
discs.
Preparation of lnsul in Standards.
Preparation of First Stock Solution (200 µg/ml)
10.0 mg of lnsulin (Sigma, Bovine pancreas insulin recrystallized, product #15500, assay 23,4 internatio~al units)
was weighed out and placed into a small beaker (10.0 ml)
and dissolved with 2 - 3 ml of 0.03 M HCl.

This solution

was transferred quantitatively to a 50 ml volumetric flask

)

.
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and deionized water was added up to the mark.

Aliquots of

0.1 ml were dispensed in small vials and stored at -20°C.
These preparat1ons were found to be stable for several
months.
11

Preparation of Second. Stock Solution (2

µ

g/ml)

2 ml of buffer B (see buffer preparation) was added to one
of the vials containing 0.1 ml of the first stock solution.
After careful mixing, the solution was transferred quantltat ively to a 10 ml volumetric flask.
to the mark with buffer B.

The flask was filled

This solution was prepared

fresh for every assay and kept at 4°C until used.
111

Initial Working Standard (20 ng/ml)
0.5 ml of the second solution was placed in a 50 ml volumotr ic flask and diluted to the mark with buffer B.

From

this solution a series of standard solutions were prepared
according to the following

table~

l.
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TABLE 111

WORKING STANDARDS
Initial Working
Standard

Buffer B
ml

Final Insulin
Concentration ng/ml

Concentration
uU/ml

0.2

9.8

o.4

10

2

0.2

4.8

0.8

' 20

3

0.2

1.8

2.0

50

4

1.0

4.0

4.0

100

5

1.0

1.5

8.o

200

6

1.0

20.0

500

Standard
Number

The radioimmuno assay was run in 5 duplicates since the sensitivity
up to 5 micro units of the test creates rather high deviations among
samples having the same i.nsulin concentration.
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TABLE· IV
TUBES IN RADIOIMMUNOASSAY OF INSULIN
FINAL COMPOSITION OF SAMPLE
..
. ,.,, ....

Tube #

I nsu Jin
I nsu Jin
Binding Standard
Reagent
(0. 1 ml) (0. 1 ml)

Buffer
~

1251Insulin

(0. l ml) (0. 1 ml)

Buffer
A

Insulin
µl/ml

Concentration
ng/ml

(0. 1 ml)

+

Std.

+

10

0.4

+

Std. 2

+

20

0.8

15

+

Std. 3

+

50

2.0

15 - 20

+

Std. 4

+

100

4.0

~o

- 25

+

Std. 5

+

200

8.0

~5

- 30

+

Std. 6

+

500

20.0

:o - 35

+

+

0

0

0

0

0

0

l - 5

·5 - 10 "
10 -

+

:5 - 40

+

45

++

0 -

++
+

Tube #30-45 represents the control.

I~
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. Data Evaluation.
If one plots the increasing concentration of insulin· (abscissa)
vs. the counts (ordinate) one will obtain a kind of exponential curve.
However, if the concentrations of insulin vs. the counts are plotted on
a semi-logarithmic scale, an approximate straight line is obtained.
The author, however, preferred to plot all his results and evaluate
them with the so-called

11

Hales and Randle Plot 11 (127).

the plot was worked out in the following manner:

In principle,

if a given volume

of a solution of 125 1-labeled insulin, of c~ncentrations 2i
specific

activity~

0

and

is mixed with ao equal volume of buffer or a

solution of unlabeled insulin of concentration 2i, then the concentration
of 125 1-labeled insulin w!ll be i

0

in each case, but the specific activi-

ty will be reduccid in the presence of unlabeled insulin to xi /(i +i).
0

0

It follows that the change in specific activity will be a function of
i and that the latter may be estimated by reference to a known standard
solution of insulin, if the changes in specific activity can be measured.
The theoretical relationship for the principle of isotope dilution
as applied to the immunoassay is as

fo~lows:

Let C be the radioactivity of the insulin-antibody complex when
0

is zero.
Let C. be the radioactivity of the insulin-antibody
I

co~plex

when the

concentration of unlabeled insulin is i .
Let l

0

. 125
+ I be the amount of
I-labeled insulin bound by antibody,

then under these conditions,
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I

I

0

= i 0 + i/i 0 + l

c0 = x I0 and c.I = x
and c0 I c.I = I 0 I I
then c0 I c.I = i l/i 0 +
and

It fol lows that

c0

I

c.I

will be linearly related to i ' that C I
0

wf ll be unity when i is zero, that i
-

is minus

-0

c.I

when C I C. is zero
0

I

and that the slope of the line is 1/i .
0

The theoretical relationship holds only if one assumes that the
affinity of the antibody for 125 1-labeled insulin and unlabeled insulin is the same.
The Rat Hemi-diaphragm Assay.
As stated in the chapter

11

Assays of .Insulin in.Blood" the hemi-

diaphragm method was employed in order to measure insulin as well as
insulin-like activity.

The radioimmunoassay measures only free

immunologically active insulin.
Procedure.
a.

Animals and tissue
The animals
Madison,

use~

were male albino rats supplied by Holtzman,

Wi~consin.

Laboratory Chow.
120 and 140 gm.

The rats were fed ad libitum with Purina

The rats at the time of use weighed between
Twenty four hours prior to the experiments

the rats were kept in separate cages and fasted.

The diaphragm

was dis sec t·ed and used.

l
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Incubation flasks.
The flasks used.for the incubation were Erlenmeyer flasks
holding 10 ml.

They wer: stoppered with sleeve-type stoppers

and small plastic cups with a plastic holder were pushed through
the stopper.
Incubation Media.
The buffer solution used for the incubation was prepared according
to the protocol out 1 i ned ·by Gey and Gey ( l 08).
)

TABLE V
Concentration
g/l

Mo 1. cone.

g/l

Quantities
for B.S.S.
ml per liter

NaCl

7.00

5.0

292.20

24.0

KCl

0.37

1.0

74,55

5.0

2.27

J.O

84.01

27.0

o. 17

0.1

1]. 1

15.3

J.O

203.33

1.0

o. 15

0.5

89.03

1. 6

0.03

J.O

136. l 4

0.2

0.07

0. 1

24.65

3.0

Constituents

NaHC0
CaC 1·
MgC1

3

2

(.anhydrous)

' 6 H0
2
Na HP0
2 H0
2
4
2
2

KHlo 4
MgS0

4

' 7 H0
2

0. 21

Stock Solution

!'

In order to achieve physiological pH, the buffer has to be equilibrated
with a gas mixture of 95%

o2

and 5%

co 2 .

The glucose concentration

of the mixture was 300 mg per 100 ml of buffer.
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·Preparation of Solution containing Glucose-1- 14c.
For each batch of tracer glucose, 50

Ci of glucose-1- 14 c

(Amersham/Searle Cai, Arlington Heights, Illinois) was diluted to
a concentration of 0.5

Ci per 0.1 ml.

Preparation of Insulin Standards.
A single batch of insulin has been used for this experiment
(fryst. insulin, Sigma Chemical Co., batch #llC-1210, 24.3 l.U.
per mg}.

A concentrated insulin standard was prepared by dissolving

10.mg of insulin in 10 ml of deionized water.
standard thus contained 24.3 units per ml.
at 4°C.

The concentrated

This solution was stored

Before running the assay one ml of this solution was brought

up to 24.3 ml with deionized water, so that 1 ml contains 1 U.

From

this solution 1 ml was taken and diluted 1 to 100 with incubation
buffer containing glucose.

The insulin concentration was then 10 mU

per mlj 1 ml of this dilution was further diluted l to 10 with the
same buffer to bring the final concentration to 1,000 micro units
per ml.

From this concentration, serial dilutions were prepared to

obtain concentrations of 1,000, 500, 250, 125, 62.5 and 31.25 uU
per ml.
Assay

Technique~

Principle.
Rat hemi-diaphragms were incubated in Gey-Gey buffer with
glucose-1- 14 c for 2 hours ~t 37°c.

At the end of the incubation, the

l
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14

c

incorporation into glycogen was also determined.

of 14 c incorporated into glycogen and co

2

The amount

was then rel~ted to the

insulin present in the medium.
Procedure.
Into each assay flask, 1.9 ml of unknown solution or standard.
solution was pipetted.

Exactly 0.1 ml of glucose-1- 14c was added

making the total incubation solution 2 ml.

The flasks were then

weighed to the nearest mi 11 igram and kept. stoppered to prevent
evaporation.
After the flasks were prepared, rats were killed by a blow on
the head followed by decapitation.
as rapidly as possible and placed
an ice bath until used.
parts and placed into the

The diaphragms were dissected

}n

Gey-Gey buffer, and cooled in

The diaphragms were cut into two equal
incubatio~

flasks.

The flasks were then

\

re-weighed to'determine the weight of the hemi-diaphragm.· After
gassing for l minute with a gas mixture of 95% o2 and. 5% co using
2
#21 'hypodermic needl.es inserted through the rubber stoppers, the

needles were withdrawn and the system was left airtight.

The in-

cubation flasks were then put on a metabolic shaker for 2 hours at
37QC.

Particular caution was taken to maintain the physiological

pH of 7.35 - ].40.
Liquid Scintillation

Countin~~

The counting of the radioactivity of isolated glycogen of diaphragm, was performed in a Beckman LS-250 counter.
counted three times for 10 minutes each.

Each sample was

r
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!

Scintillation Fluid.
The cocktail was comprised of scintillation grade toluene,
5 g PPO per 1000 ml find of Bio-Scilve BBS-3, 20 ml plus 100 ml of
the toluene-PPO mixture.

The technique of determining the radio-

. .
"
done accor d"1ng tote
h procedure
activity
o f 14 C .in g l ycogen,was

pub! ished by Rafaelsen and coworkers (104).
Isolation of Glycogen.
After the incubation period, the

pr~-weighed

hemi-diaphragms

were placed in glass centrifuge tubes (12 x 100 mm).

Three ml of

a 30% potassium hydroxide solution. were added and the contents were
heated for 30 minutes in a waterbath at l00°C.

After hydrolysis,

the glycogen was precipitated by the addition of 0.2 ml of 2,5%
sodium sulphate and 1.6 ml absolute ethanol for each 0.5 ml hydrolysate.

After keeping the samples for 18 hours at -15°c, the samples

were centrif.uged in a precooled (-15°C) International Refrigerated
·Centrifuge for 20 minutes.
and discarded.

The supernatant was carefully decanted

After decantation and draining, the precipitates

were washed twice with 2.0 ml of cold 66% ethanol (v/v) and centrifuged.
The precipitates were then dissolved in exactly 1.0 ml deionized water
and aliquots were taken and placed in liquid scintillation vials.

The

results were plotted on linear graph paper, (counts per minute per
gram of tissue vs. the concentration of insulin standard or unknown).
The curve which resulted from the insulin standard was a straight line.
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The ln Vivo lntraperitoneal Assay for lnsul in.
The

intraperiton~al

.!.!2.

vivo bioassay was performed, basically,

according to the technique outlined by Rafael sen and coworkers (104)
with some minor modifications, as described by Young and coworkers

034[.
Animals.
The animals used were the same as described in the hemi-diaphragm
assay (p9ge 42}, except that their weight' was between 90 - 120 grams.
Materials.
Radioactive glucose (D-glucose- 14 c (U} with a specific activity
of 2..9 mCi/rnM or 16. 1 µCi-mg glucose was used in al 1 experiments.
The D-glucose- 14 C (U) was obtained from Amersham/Searle, Arlington
Heights, Illinois.

The insulin used for preparing the standards

was bovine insulin, from pancreas, 24.6 IU (Sigma Biochemica)s),
The bovine albumin was replaced by PVP polyvinylpyrrol idone from
Matheson-Coleman and Bell, Norwood, Ohio.
·procedure.
The small male rats, faster for 24 hours, were injected. intraperitoneal ly with 1.5 ml of the test solution.'
The test solution was composed of:
al

2 µCi D-glucose- 14 c (U)

b)

1 mg D-glucose

c}

5% PVP (w/v}
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d)

the whole mixture was dissolved in physiological saline

e)

insulin in various concentrations as well as unknown tast
..
substances~-

The injections were made on the right side, midway down the
abdomen.

Once the injection of fluid starts, the needle must not
1

be moved, otherwise it is impossible to say whether or not some
of the fluid may go into the intestine rather than into the cavity.
Lt is recommended that the needle be inserted at an approximate
angle of 25°.

Leakage through the puncture can be prevented by

releasing the rat 1 s leg when the injection is completed and waiting
for a further 5 seconds before withdrawing the needle.

After in-

jection, the animals were individually returned to their respective
cages.

An important detail ·of the procedure, which has been kept

nearly constant throughout, is the time interval in which the
animals were injected and sacrificed.

Each rat should be killed

. 2 hours after injection.
The .rats were sacrificed by a blow on the head and subsequent
decapitation.

The diaphragms were removed as follows:

the xiphoid

cartilage was grasped with forceps, at a right angle to the rat,
and twisted half a turn so as to depress the ribcage and expose
the diaphragm.

The diaphragm was then punctured with sharp forceps

or with a scalpel, in the central non-muscular area between the.
inferior vena cava and the xiphoid process.

This releases the

negative pressure in the chest and causes the diaphragm to billow

L
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out.

The diaphragm was grasped with forceps at the plqce of puncturing

and the right and

lef~

hemi-diaphragms were dissected.

Without

releasing the grip on the tissue, the severance was completed by
cutting around the margin of the ribcage.

The dissected tissue was

washed in saline, dried and immediately frozen with dry ice.

After

freezing the tissue, it was weighed and placed in glass centrifuge
tubes and hydrolyzed with 30% KOH.

The isolation and counting of

the glycogen was performed in the same manner as in the previously
described rat hemi-diaphragm bioassay.
Rat.:. Adipose Tissue'Bioassax.
The third and last bioassay which was employed ,to determine
insulin-like activity was the rat-adipose tissue bioassay.

As al-

ready pointed out in "Assays of lnsul in in blood 11 (page 21), this
assay exhibits the highest sensitivi'ty of all the bioassays.

How-

ever, it also is the least specific in so far as it responds to
insulin-like activity from compounds other than insul,in.
·Procedure.
This bioassay was performed basically in the same manner as
the rat hemi-diaphragm bioassay.
Animals and Tissues.
See rat hemi-diaphragm assay.
· lncubation Flasks.
The flasks used for the incubation were the' same as described
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in the hemi-diaphragm assay (Corning Culture Flasks).
Incubation Media.
The buffer solution for the incubation of the adipose tissues
was Gey-Gey buffer.
page 43.

Its preparation and composition is given on

The preparation of the glucose-1-

14

c

containing solution

as well as the preparation of the insulin standards are identical
to those described and used with the rat hemi-diaphragm assay
(page 44}.

Principle of the

Assay~

Rat adipose tissue is incubated in Gey-Gey buffer with
glucose-1- 14 c for 2. h_ours.

co2

At the end of the incubation, the total

present in the system is liberated by the addition of acid

added to the medium and is trapped in ~mall -amounts of NaOH which
is in the trap.

The sodium carbonate so obtained is transferred

in exact aliquots into a scintillation vial and its radioactivity
determined. - The total radioactivity of the

co 2

is expected to be

directly proportional to the amount of the first carbon of glucose
oxidized to

co 2

and, as will be shown later, is further related to

the amount of insulin present in the system.

When the radioactivity

per gram of adipose tissue is plotted against insulin concentration,
the shape of the plot took the form of a sigmoid curve.

If one

plots the logarithm of the counts (ordinate), then a straight line
r

/.
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in~ulin

up to 500 uU of

can be obtained, making a standard curve

which is very suitable for the evaluation of the unknow~s.
Isolation of the Insulin-Protein Complex

(IPC)~

Materials.
Human serum was obtained from.the clinical chemistry laboratory
of the Foster G. McGaw Hospital of Loyola University of Chicago.
The serum was collected from numerous patients, pooled and immediately frozen.

The final pool should thus. represent a good cross-

section of sera.

Frozen human plasma from healthy persons was ob-

tained through the courtesy of the Hematology Department of Presbyterian-St. Luke 1 s Hospital, Chicago, Illinois.

The cationic

exchange resin used was Sephadex C•50, Amberlite IRC-50 (Fisher
Chemicals}, BioRad Rex 63 (BioRad Laboratories), and Dowex 50
(Baker Chemical Corporation).
G-200.was used.

For the gel filtration, Sephadex

All Sephadex products were purchased from Pharmacia

Fine Chemicals Inc., Pescataway, New Jersey.

Except for those

.studies which compared the effectiveness of the resins for the
isolation of the IPC, Sephadex C-50 was used to isolate the insulin-protein complex.
Isolation Method Using Sephadex C-50.
ln each case, 500 ml of pooled human serum was stirred for

3 hours at 4°C with 10 g of Sephadex C-50 resin.

The Sephadex

resin was allowed to hydrate overnight prior to use.

The mixture
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was then filtered on a Buchner funnel.

The recovered resin was

"
subjected to repeated washings with
2 - 3 liters of cold deionized
.;'

water.

I

The washings were performed with the Sephadex resin on the

Buchner funnel.

A column m~asuring 2.5 x 100 cm (columns were

obtained from the Pharmacia Company) was then packed with the prewashed resin.

To remove further anionic and neutral proteins, a

0.005 M aqueous solution of ammonium carbonate was run through the
column until a steady baseline was reached on a UV monitor.

The

collection of the fractions and the monitoring of the protein
content was done with a full automatic fraction collector unit
(LKB Produkter A B, Sweden; UV Control unit Type 8300, Recorder
Type 6520-3, Ultraviolet Detector Type 8303 A and Fraction Collector
Type 7000).

The entire unit was kept .Jn a coldroom in which a

constant temperature of 4°C, was maintained.

A salt gradient of

ammonium carbonate from 0.005 M to 1.0 M, was applied to the column
at pH

7.8.

The flow rate of the column was adjusted to 0.5 ml per

minute with the aid of a peristaltic pump (LKB).

Each elution peak

which appeared with increasing salt concentration was pooled and
the pH was adjusted to 7.3 .:.. 0.1 with acetic acid.

Following the

pH adjustment; the pooled peaks were desalted and concentrated with
an Ultrafiltration apparatus (Ami con Corp., Lexington, Massachusetts),
using a UM 10 membrane which permits passage of all substances below
a molecular weight of 10,000.

L
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The concentrated elution peaks were freeze-dried.

All peaks

were then tested for insulin-like activity with the rat hemidiaphragm bioassay.

Before performing the bioassay, the protein

fractions were dissolved to attain a predetermined protein concentration in Gey-Gey buffer pH

7.4 and dialysed for approximately

8 hours against the same buffer with various changes during this
period of time.
Isolation of IPC with Other Cation Exchange Resins.
The commercially available resins were first v1ashed \vith deionized water until fine particles were removed and the supernatant was colorless.

A specified amount of each individual resin

v/as treated \-Jith 3 times its volume of 3M HCl and stirred for
about 20 minutes.

The HCI was then decanted and the resin

until neutral with deionized water.
1 U

~~aOH

~ashed

An alkaline treatment with

vias followed to convert the resin into its sodiun forn.

The

amount of NaOH to achieve conversion to the sodium form was aporoximately three times the volume of the resin.

This material was then

washed once more until neutral vdth normal saline· {0.15 M NaCl).
The i4a+-resins were then stirred with pooled human serum, 5 tir:ies
the amount of the resin, for 5 hours in the cold room at 4°C.
resin was

1he

then allowed to settle and the serum was decanted,

frozen and stored for determination of insulin-like activity which
was not absorbed.

The recovered resin was packed in a column and
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saline was used to elute all physically absorbed proteins.

Once

a steady baseline on the UV monitor was reached, a potassium
chloride gradient, 0':15 M to 3M KCl, was employed.

The elution

peaks were dialysed and concentrated with an Amicon Ultrafiltrator.
To obtain proper physiological buffer concentrations (Gey-Gey) for
the hemi-diaphragm bioassay, BioRad Cellulose fiber dialysis was
used

L 163).

Gel Filtration Chromatography.
Gel filtration was carried out exclusively with Sephadex
products, G-75, G-150, and G-200.

The Sephadex powder in all

instances \iJas allowed to hydrate according to the specifications
outlined by the Pharmacia Company.
desired hydrated Sephadex and
various buffers.

Columns were packed with the

subsequ~ntly.

equilibrated with

The elution peaks were recorded with LKB UV

monitor at 280 nm.

The flow rate was regulated with the aid of

a LKB peristaltic pump.
Procedure for the Determination of Lysozyme.
The lytic activity of lysozyrne was measured quantitatively by
the radial diffusion-gel technique described by Schumacher and
Wied (136) and Osserman and Lawler (137) using agar.gel containing
suspended dried

11

Micrococcus lysodeikticus 11 cell walls.

1% Nobel

Agar (Difeo Laboratories, Detroit, Michigan) solution was prepared
in S¢renson buffer, pH 7.0 (138} and 30 mg Micrococcus lysodeikticus
were added to 100 ml dissolved agar which had been cooled to 50°C.

(

r
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The liquid ag~r was then applied to a LKB immuno-diffusio~ set
(LKB Instruments, Rockville, Marylahd).

Micrococcus

ly~odeikticus

were obtained from \forthington Biochemical Corp., Freehold, New
Jersey.

Standaras, as well as samples, with unknown. lysozyme con-

centrations were placed into wells cut in the agar with a LKB wellcutter.

The enzyme diffused radially and lysed the Micrococcus agar

forming transparent discs around the well.

The diameters of these

discs depended on the concentration of the enzyme.

The substance in

the wells were allowed to diffuse in an incubator at 37°C for 6
hours.

Chicken.egg white lysozyme (E.C 3.2.l.7 muramidase, salt

free twice crystallized, Worthington Biochemical Co.) was used as
a standard.

The st.andards were prepared in the same salt concentra-

tion as those of the unknowns to a;sure equal diffusion rates.

The

results of the method were plotted on a semilogarithm paper (radius
'

of lysis (abscissa) vs. lysozyme concentration (ordinate), log scale).
Determination of the Molecular Weight of Insulin-Protein Complex
With the Gel Filtration Method.
For this purpose, a Sephadex G-200 column (100 x 2.5 cm) was
prepared and equil tbrated with a 0.05 M Tris - -0.l M NaCl buffer
pH 7.4.

The void volume was determined with Blue Dextran, MW about

2.,000,000.

Proteins with known molecular weights were run individually

on the column •

..
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a

Aldolase

10 mg

MW

158,000

b

Ovalbumin

10 mg

MW

45,000

c

Chymotrypsinogen A

10 mg

MW

25,000

cl

Ribonuclease A

10 mg

MW

13,700 ·

The enzymes 1;1ere supplied by Worthington Biochemical Co. and
distributed in a kit by Pharmacia Fine Chemicals, Inc.
tein resulted in a single symmetrical peak.

Each pro-

The number of test

tubes (5 ml/tube), counting the tubes from the start to the midpoint
"of the peak, were plotted on semi-log paper (MW log scale on the
ordinate and tube number, volume, on the abscissa), obtaining a
straight 1 ine.

The elution peak of the insulin-protein complex

was then compared to this plot and the molecular weight estimated.
The conolex was of course run over the same column under the same
conditions.
Preparation of Crude Adipose Tissue Extract.
The adipose tissue extract {ATE) was prepared essentially
according to Antoniades (60).

Pooled rat epididymal fat pads from

animals supplied by Holtzman, Madison, Wisconsin, VJeighing between

180 and 220 grams, were homogenized in normal saline (0.15 N NaCl)
in the coldroorn a: 4°C with a VirTis 45 homogenizer.

The ratio of

tissue to saline Has maintained at 10 g fat pads to 50 ml of saline.
The homogenate was passed through a cheese cloth to remove fat and
tissue debris.

The filtrate was then subjected to a 30 minute
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centrifugation in a
The upper layer

pre~cooled

consi~ting

Sorvall centrifuge at 15,000 g.

of solid as well as liquid 1 ipids was

carefully removed and the supernatant collected.

The clear solution

was then brought up to 60% ethanol (v/v) by adding, under constant
stirring, 100% ethanol.

The temperature of the mixture was main-

tained at 0°C in an ice-bath containing sodium nitrate.

After l

hour, the precipitate which had formed was centrifuged and discarded.
The ethanol of the supernatant was evaporated with a rotary
evaporator.

The remaining liquid was then passed through an

Amicon ultrafiltration apparatus using a UM 2 membrane which permits
the passage of substances below a molecular weight of 1,000.

The

filtrate was then concentrated and desalted on a Sephadex G-10
column (100 x 1.0 cm}.

The eluant from the column was lyophil ized.

and the powder used for assaying the insulin-protein complex with
the hemi-diaphragm assay.

Besides rat epididymal fat pad

ti~sue,

human· mesenteric fat (postmortem, kindly suppl led to us by the
Depq.rtment of Pathology of Foster G. McGaw Hospital, 'Loyola University
of Chicago) was used to prepare adipose tissue factors.

/

CHAPTER 111
RESULTS
The purpose of this dissertation is to attempt to determine
the validity regarding conflicting reports in the literature, that
substances whlch exhibit insulin-like activity other than insulin
itself, are present in human plasma.
We were, in particular, interested in whether or not insulin
circulates in plasma as an insulin-protein complex.

In order to

pursue this task, insulin assays had to be set up to measure immunoreactive insulin.

The following insulin assays were chosen:

a.

the radio immunoassay

b.

the in vitro rat diaphragm bioassay

c.

the in vivo rat intraperitoneal bioassay

d.

the in vitro rat adipose tissue bioassay.

-

--

The radioimmunoassay was set up according to Hales and Randle (127).
Only one modification was introduced, namely bovine albumin which
is required in all buffer solutions was replaced by PVP (146).
Gre.::it emphasis

~vas

placed on the choice of the filter discs 1,1hich

have to be used to filter out the insulin-antibody complex.

Studies

by Przybyla (146) revealed that the Mi 11 ipore filters supplied by
Searle/Amerhsam gave results v1hich were not reproducible.
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filter discs \-Jere therefore used in all immunoassays, due to their

excellent filter properties and reproducibility of results.
A set of bovine insulin standards 1-1as prepared, as shovm in
Table I I I.
insulin.

They ranged in concentrations from 10 to 200 µU/per ml of
The 1-;orking solutions of labeled insulin and insulin

binding reagent 1-;ere prepared as discussed in "Materials and Methods",
page 39.

The samples were counted for 10 minutes with Fluor I II as

the scintillation medium.
-Figure l.

The results are listed in Table VI and

All results were corrected for fluor background and wash

controls.
The rat diaphragm bioassay was performed according to VallanceOv.;en et al (159).

Minor changes were e:.iployed as far as the glu-

cose concentration of the incubation media was concerned .. Glucose
concentrations of 300 mg/100 ml were used instead of 250 mg/100 ml,
because the incorporation of glucose
to bi more pronounced.
page 42 •

i~to

the muscle tissue appeared

The methodology is outlined in detail on

As seen on Figure 2 and Table VI I, the diaphragm assay

is not linear, when the insulin concentrations fall below 20 µU,
Above 20 µU and up to 250 µU, the assay is linear and reproducible,
and therefore is suitable for estimating insulin within these ranges
of concentrations.

(Above fasting values in normal persons.)

The rat intraperitoneal bioassay 1r1as chosen to determine the
activity of insulin and its insulin-I ike substances under more
phystological conditions.

This assay, in comparison to the other
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TAB LE VI
RADIO-IMMUNE ASSAY STANDARD

# of Tests

Insu 1in in

1
2
3
4
5

CPM

Co/Cl

Co/Cl
+ S.E.M.

10
10
10
10
10

8880
8864
8175
8631
8932

1. 142
1. 144
1.241
1• 17 5
1. 136

1.167 .!.. 0.019

1
2
3
4
5

20
20
20
20
20

8541
8647
8034
8624
87·03

1. 188
1. 173
1. 263
1• 176
1• 166

1.193 .!.. 0.017

2
3
4
5

50
50
50
50
50

7333
6573
5847
6992
6996

1.384
1. 544
1. 735
1•451
1•451

1• 513 .!.. 0. 061

1
2
3
4
5

100
100
100
100
100

5642
5246
4784
5258
5140

1. 798
1.934
2. 121
l'. 930
1.974

1
2
3
4
5

200
200
200
200
200

3774
3571
3908
3251
4104

2.689
2.842
2.596
3. 121
2.473

1
2
3
4
5

0
0
0
0
0

9922
10306
11065
9929
9526

µU

'

Average CPM
+ S. E. M.

1• 951 .!.. 0.052

2.744 + 0.218

10149 .!.. 265.6

·· .

. :J':•

Figure 1.- Standard curve of the radioimmunoassay, as plotted
according to the method of

11

Hales and Randle 11 •

the graph was obtained from five duplicates.

Each point on
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I nsu I in
µU

Tissue
mg

CPM

CPM/gm
Tissue

CPM/S.E.M.

1
2
3
4
5

50
50
50
50
50

368
343
391
411
317

10723
9892
11773
11465
9014

29138
28839
30111
27897
28437

. 28884 ! 310

1
2
3
4
5

100
100
100
100
100

291
307
252
271
311

9242
9508
8215
8126
9662

31762
30971
32600
29986
31070

31277 !447.

1
2
3
4
5

150
150
150
150
150

. ,381
443
411
289
367

. 13901
15689
15918
9881
13203

36485
. 35415
38732
3419l
35976

36159 ! 749

250
250
250
250
250

247
267
367
342
298

10431
11107
16519
13619
11916

42230
41599
45011
39823
39989

41736 !942

--

341
360
401
402
371
290

6856
6948
9515
7076
8500
5438

20105
19300
23728
17601
22911
18751

20399 ! I 083

Animal
N=5~"

1
2
3
4
5
I
2
3
4

l

5

6

*

..

. ------

--

Five different rats have been used for every point.
TABLE V11

O'
N

Figure 2. - The graph represents a typical standard curve when
crystal I ine bovine insulin is assayed with the rat hemi-diaphragm
bioassay.

The standard values on the graph represent five

individual rats with similar body weight.
x 10,000 expresses

14

The

CP~

on the ordinate

C-glucose incorporation into muscle glycogen.
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assays, has the advantage in that high insulin concentrations, up
to 10 mU, can be measured.

However, it has disadvantages which are

cor.imon to all other in vivo assays.

Unknown factors in the intact

animals cannot be controlled and therefore may obscJre the results;
furthermore there exists the unpredictability of the test animal.
The results from the.!.!: vivo bioassay, which was carried out according
to Rafael sen and coworkers, are listed in Table VI I I and Figure 3.

--

__ ----

Finally, the data for the standard curve of the rat ____,_
adioose tissue
bioassays are shown in Table IX and Figure 4.
in the

11

As pointed out earlier

lntroduction 11 , the procedure outlined by Martin and Renold

was utilized,

It can be seen from the graph that this assay has

a limitation when it comes to measuring insulin concentrations above
500 uU.

Jue to the lack of specificity, this

partic~lar

bioassay

procedure was adandoned.
Isolation of the lnsul in-Protein Complex by Cationic Exchange
Chronatograohy.
In the literature review of bound insulin, it was pointed out
that workers in several laboratories tried unsuccessfully to duplicate
AntoniaJes

1

work, namely the isolation of bound insulin.

Przybyla

(146), in this laboratory, obtained preliminary evidence that in

human plasma there could possibly be a compound exhibiting insulinlike activity, when Antoniades 1 methods were employed for the isolation procedure.

It was, therefore, decided to reinvestigate this

problem using various isolation procedures.

Antoniades 1 procedure

as foll01.1ed by the author is outlined belmv, in brief form.

Rats

N= 5
1

2
3
4
5
1

2
3
4
5
1

2
3
4
5

CPM

50
50
50
50
. 50

269
251
243
261
239

1035
1008
951
1024
955

3847
4015
3913
3925
3998

3939 ± 12

100
100
100
100
100
200
\ 200
200
200
200

338
305
285
290
315
332
304
310
283
309

1361
1370
1281
1293
1354
1649
.1375
1507
1407
1481

4023
4493
4512
4459
4299
4878
4523
4861
4972
4889

4357 ± 64

269
444
370
290
319

1511
2438
2039
1583
1798

. 5617
5491
5511
5459
5637

5543 ± 36

4459
4400
4246
3207
3218

10982
11000
11173
·10762
11073

10998 ± 68

1000
1000
1000
1000

406
400
380
298
344

------

323
452
410
402
375

1046
1195
1120
1039
1009

3238
2643
2733
2586
2691

2778±118

2
3
4
5
1

· lOOO

2

3
4
·5
1
2

3
4
5

CPM/gm ± S.E.~\:·-

Tissue
mg

500
500
500
500
500

1

CPM/gm

lnsul in
µg

j

.

~;

TAB LE V 11

Tissue

''·.

4825 ± 245
c;

v

...
i

Figure 3. -

This standard' curve is obtained when crystalline

·bovine insulin is assayed J..12. vivo with the rat intraperitoneal
bioassay technique.
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ADIPOSE-TISSUE BIOASSAY - STANDARD CURVE

µU

Tissue
. mg

63

530

17424

32875

63

405

13732

33906

2

125

503

22992

45709

2•

125

509

21328

41901

3

250

560

36384

64971

3' -

250

653

45666

69932

4

500

537

73964

137735

41

500

411

57682

140345

5

1000

812

121442

149559

5'

1000

767

113634

148153

6

-.

439

10394

23676

6'

-

455

11300

24835

Rat
No. ·k

} I

..

Insulin

J

CPM

CPM/gm Tissue

J.

"land l' means one rat each of the epididymal fat pa_ds v;ere used in the assay.
TABLE .IX

CPM/gm Tissue
Average

33340

'....

43805

67451

139040

148856

24255

68

TABLE X
,·

ADfPOSE TISSUE BIOASSAY

Insulin
µU
63

CPM/gm Tissue
± S.E.M.

33760

±

735 (3)

125

44017 ± 917 (3).

250

67924 ± 498 (3)

. 500

140068 ± 916 (.3)

1000

149853 ±1093 (3}
23621

±1377 (3}

Summary of three independent runs •

-

.

Figure 4. - The graph represents a standard curve of crystalline
bovine insulin when rat epididymal fat pads are used as the target
tissue for insulin.
tissue x 10,000.

The ordinate shows the CPM per gram of fat

The data on the graph is the result of the

average of three rats.

Both fat pads w~re assayed individually.

''
''
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A column {2.5 x 50 cm) was packed with Dowex AG 50-X8 (sodium
form, analytical grade) and equilibrated with 0.15 H ilaCl for 4
hours.

Following the saline equilibration, the resin was washed

with 3 1 iters of a 0.15 N di basic sodium phosphate, solution until
a pH of 6.6 was reached.

300 - 500 ml of pooled human serum was

then passed through a column containing 175 ml of the resin, at a
rate of 8 ml per minute.

Once the serum had passed through the

resin, the resin was vJashed vtith two column volumes of 0.15 ti iJaCl
to remove contaminating substances.

The IPC was then eluted with one

column vol1me of 0.1 tl ammonium hydroxide.

The pH of the eluate v1as

monitored with a pH meter and kept at pH 7.0 + 0.5 VJith 2 tl H2 S04
s.olution.
dried,

After dialysis against 0.15 N NaCl the eluate ·.;as

To test the freeze-dried fraction, it was

freez.~

redisscivE~

:~

a

specified volume of buffer and dialyzed against Gey-Gey buffer for
24 hours at 4°C with several buffer changes.

The dialyzed

~re:ara

tion was then tested with the rat diaphragm method to which
adipose tissue extract v.;as added (see

69).

11

a~

Materialsand Methods 11 , page 56

The result of this experiment, which was repeated sever3l

ti~es,

was negative, thus confirming the reports by Mead (75) and by Serso'1
and Yalow (76) concerning inability to reproduce the rcsul ts
by Antoniades.

re~~rted

There are a number of explanations for our failure to

reproduce Antoniades

1

work.

As early as 1932, Jemen and Evans (140)

reported that insulin is destroyed rather rapidly in aqueous solutions

71

at pH values over 9.1.

To elute the IPC, Antoniades used ammonium

hydroxide solutions with pH values approaching 11.

Du Vigneaud, in

1941 (141), and Cavalli, in 1970 (142), confirmed the work of

Jemen and Evan.

They gave as a reason the hydrolysis of the amide

bonds and the disruption of the cystine bond in the ,insulin molecule.
Schultz et al. in 1962 (144) and Grannis in 1960 (143) reported that
dilute acids may also denature the hormone by hydrolyzing the asparagine and glutamine residues.

The use of 2 N H2 so4 for neutral iza-

tion cre~tes locally elevated concentrations of hydrogen ion which
may destroy the hormone.
Kuzhetsova and Samsonav,· in 1969 (145), showed that strong
basic, as well as acidic ion exchange resins may
sulin.

als~

denature in-

This finding convinced us that the methods used by Antoniades

and coworkers· were too harsh, and probably.were responsible for the
loss of insulin activity in our preparations.
We turned, then, to the development of mi.Ider isolation techniques.

We tried three different cationic exchange resins, Sephadex

·c-50, BioRad Rex 63, and Amber! ite ICR 50.

BioRad Rex 63 has phos-

phate and Sephadex C-50 and Amberl ite have carboxyl residues as the
active groups, instead of sulfate groups, as in Dowex AG 50-'X8.
reason for using thes~ resins was twofold.

The

First, hydrolysis of

insulin can be minimized due to its rather weak acidic groups and
secondly

~lutions

of the IPC requires milder eluants.

The result of

I

Figure 5. - Elution profile
on Sephadex p-50.

when human serum was chromatographed

Four peaks, absorbing at 280 nm were obtained

4 2co 3 gradient ranging from 0.005 M + J.000 M pH 7.8

when an (NH )
was used.

.

The

~haded

activity expre~ed in

area over peak 4 represents insulin-1 ike
,µU

as assayed with the rat diaphragm

bioassay.

.

.

72

0

0

IO

nn

•

0

A.LIAl.&.OY Nl,n•NI

•

0

IO

ID

~
,,

....
..

0
0

0
G)

•

-•..
IJ
:I

IL

E
~

ID

•

a ::>

Ill

D

..

0

et

..

0

0

•

..:WU

088 A.l.IDNDG -

,YOl.&.41110 O

..,

ILA DISTRIBUTION OF HUMAN SERUM OBTAINED WITH SEPHADEX C-50.
TABLE XI
ATE
100 µg Protein
Pe;ak
Peak

'

II

· Heparin
100 µg

0

0

0

0

(Biotin
10 µg

.
<

.,.--.,

0

±
~

Peak I I I
Peak

±

+++
·++++

IV

±

±

±

+++

+++

++++

Mbans traces.
Means between 200-300 µU of Insulin-like activity/ml serum.
Means over 300 µU of Insulin-like activity/ml serum.

The table shows the qualitative distribution of insulin-like activity/ml
of human serum. The qualitative data of ILA was obtained with the rat
herni-diaphragrn bioassay.
6

)

''·.

-...J

w

~i
TAB LE X11
COMPARATIVE TEST FOR ILA WITH DIFFERENT ION EXCHANGE RESINS.

Resin

Acidic
groups

Sephadex C-50

carboxyl

Amberlite IRC
50 - 100 mesh

carboxyl

Bio-Rad Rex 63

phosphate

Dowex AG 50-X8

sulfate

*

Insulin activity µU equivalent/ml serum
Radioimmunoassay
Diaphragm Assay
Biotin
IPC
Heparin
Biotin
Heparin
+ S.E.M.*
+ S.E.M.
+ S.E.M.
+ S.E.M.
+ S.E.M..
115 ± 20 (3)t

22 ± 15 (3)t 22 ± 15

. 107 ± 30 (3)

20±11(3)

89 ± 17 (3)

8 ±. 6 (3)

8 '±

(3)

0

5

(3)

Standard error of the mean
t Results were obtained from three different runs.

0

20 ± 11
6

. 200 ± 55 (3)t 310 ± 35 (3)t

IPC
+ S.E.M •
0

175 ± 70 (3)

293 ± 47 (3)

0

117±30 (3)

217 ± 67 (3)

0

(3)

0

10

(3)

l7

....._.
~
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the isolation of IPC on Sephadex C-50 can be seen in Figure 5 and
Table X.
11

The procedure is outlined in the section devoted to

Materials and Methods'', page 51.

All elution peaks were individually

(

pooled and tested for insulin activity with the radioimmunoassay
procedure as'well as with the rat diaphragm bioassay.
-J

Peak I, I I

and I I I Figure 6 did not show any insulin-like activity.

Using the

radioimmunoassay and the rat diaphragm bioassay, the fourth peak
showed ·considerable insulin-like activity, Figure 5 and Table X,
when the protein of peak IV was preincubated for 30 minutes with
100 µg/ml of heparin.
see page 110).

(Explanation concerning heparin will follow,

When this material was/re(ncu~?ted with 10 µg/ml

P

of biotin it showed activity only with the rat diaphragm bioassay,
but not with the radioimmunoassay.

These results indicate that both

heparin and biotin can activate the inactive IPC, but apparently by
different mechanisms.

The data comparing the

~esults

from the

different resins are summarized in Table XI I.
Purification of the IPC by gel filtration.
The insulin active fractions obtained from the Sephadex C-50
were concentrated and desalted with an Amicon ultrafiltration apparatus.

The salt free solution was then freeze-dried.

From 1 liter

of human serum an average of 2,000-3,ooo·mg of protein was obtained.
One mg of this substance represents an average of 20-40 µU of insulin equivalence.

Further purification was achieved by gel filtra-

ti on on Sephadex G-200.

An a 1 i quot of I PC from Sep.hadex C-50 was

76

dissolved in Tris-NaCl buffer (0.1 N NaCl in 0.05 N Tris buffe~) pH

7.4.

The protein solution was then appl led to a Sephadex G-200

column (2.5 x 100 cm) which had been equilibrated with the same
buffer for 5 hours.

The elution pattern is shown in Figure 6.

It exhibits five peaks, absorbing in the region of 280 nm.

To re-

solve peaks I I and I I I, IV and V, tubes #15 - 35, 36 - 42, 42 - 60,

65 - 73 and 74 - 84 were individually pooled, concentrated and rechromatographed on the same column.

7.

The result is shown in Figure

Each· elution peak was assayed for insulin-1 ike activity with

the radioimmunoassay and the rat -intraperitoneal bio,ssay.
sults can be seen in Tables XI 11

&

XIV.

The re-

This purification step

revealed 2 distinct fractions of original peak IV (see Figure 5)
which exhibit insulin activity.

A·n exciting finding was the fact

---

that peaks I I and I I I are both active with the in vivo bioassay
.

.

vJhereas only peak 111 showed activity, when tested" with the radioimmunoassay.

It is also interesting to note, that heparin as well

as biotin with the bioassay
·.!!!.vitro bioassay.

~vivo

are not as effective as in the

A possible explanation for this phenomenon may

be that the intact animal may utilize the IPC

throu~h

its own heparin

and biotin system.
Electrophoretically, the two peaks cannot be dlstinguished very
well, since both yield predominantly beta globulin bands when, the
electrophoretic separation was carried out on cellulose acetate
membranes (Beckman Microzone Apparatus).

Figure 8 shows the elution

..
~-

Figure 6. -LElution pattern of human serum insuJin protein

.

complex, when chromatographed on Sephadex G-200 with Tris-NaCl
buffer 0.15 M pH 7.4.

(Column: JOO x 2.5 cm).

.i

..
.~'

Figure 7. - .Gel chromatography (G-200 Tris-NaCl buffer pH 7.4)
pattern of the individual peaks obtained in figure 6 .. The
hatched area represents five individual. peaks which were
individually assayed for insulin-like activity.

\
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TABLE XI 11

..

.. -',,...

RAD I0 IMMU tJOAS SAY
'-·

Peak

Amount
mg •

µU Insulin Equivalence
IPC + Heparin/0.1 mg
IPC + Biotin/O.Olmg
+ S.E.M.
+ S.E.M.

r

IPC
+ S.E.M.

Ci

10
,-

~

- , !

0

(3) "'

0

0

0

0

33 !. 7

30 + 5

0

0

0

0

I

11

10

0

(3).

111

10

103 + 17

-

(3)

IV

10

0

(3)

v

10

0

(3)

* three

different runs

5

-

TABLE XIV
RAT INTRAPERITONEAL BIOASSAY

Peak

;'\

Amount
mg

µU lnsul in Equivalence
IPC + Heparin/O. 1 mg
I PC + Biotin/0.01 mg
I PC
+ S.E.M.
+ S.E.M.
+ S.E.M.

10

0

(3) "'

0

0

11

10

270 !. 25

(3)

237 + 18

-

211 + 29

111

10

133 + 70

(J)

119 !. 29

112 + 33

IV

10

0

(3)

0

0

v

10

0

(3)

0

0

three different 'runs

-

~

Figure 8. - Elution profile of whole human serum on a Sephadex
G-200 column (100 x 2.5 cm), eluted with Tris-NaCl 0.15 M pH 7.4.
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pattern of whole h~man serum, when chromatographed on Sephadex ·
G-200, demonstrating the.absolute necessity of the cationic exchange isolation step.
Determination of the Molecular Weights of Peak I l and Peak I I I.
For the purpose of determining the molecular weights of peak
11 and peak 11.1, the gel filtration technique was employed.

As

reference standards, proteins with known molecular weights were
used.

These were:
(

Aldolase

MH

158,000

Ovalbumin

MW

45,000

Chymotrypsinogen

MW

25,000

Ribonuclease

MW

13,700

.'

Only the center portion~ of the two peaks were taken and applied to
a.Seehadex G-200.column.

The

protei~s

were eluted with Tris-NaCl

.

buffer at a p8 of 7.4.and a constant flow rate was maintained with
a peristaltic pump.

The results of .this experiment are shown in

Table XV and in Figure 9.

From the elution column of ·peak I I and

I I I, and subsequent calculations and comparison with the elution
curve of the known protein peaks, the molecular weight of peak II
was estimated to be 159,000 and that of peak I I I to be 95,000 98,000.

Th.is finding showed that peak 11 was apparently the ILA-

compound isolated by Froesch and coworkers (155) which could not be
suppressed by insulin antiserum.
Since we had shown that hgparin enhances the insulin activity

. 82

MOLECULAR \iJEIGHT DE-TERMINATION OF

INSULlt~

PROTEIN COMPLEX.

Calculation
Elution volume of column
Knovm

x 100

2~5

Proteins

Dextran

159 ml

Aldolase

209 ml

Ovalbumin

312 ml

Chymotrypsinogen

354 ml

Ribonuclease

390 ml

Peak

11

208 ml

Peak 111

259 ml

CJ

All elution values are the mean of 3 runs.
Ve - Vo
Vt
Vo

K

=

Ve

= elution

volume for protein

Vo

= elution

volume of Dextran

Vt

= total

av

-

. l.o

.'1·,

bed volume

·,.
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TABLE XV
CALCULATION OF MOLECULAR WEIGHT OF ILA FRACTIONS WITH SEPHADEX G-200
Calculations of Kav:
Vt = 442 ml
V0 = 159 ml
Aldolase:

209 - 1)9

=

50
-283

=

0.176

442 - 159
Ovalbumin:

312 - 159
442
159

=

153
283

=

0.541

Chymotrypsinogen:

354
159
442 - 159

=

195
283

=

0.689

Ribonuclease:

390 - 159
442 - 159

=

231
-283

=

0.816

208
442

159
159

=

49,
_

=

o. 171

259 - 159
442 - 159

=

=

0.353

Peak

I I:

Peak I I I ;

-

283
· 100
283

Figure 9. - The graph represents standard curve for molecular
weight determination with the gel filtration technique.
curve was obtained on a Sephadex G-200 column (100 x

~.5

The
cm)

using four different proteins with known molecular weight.
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of the IPC when assayed with the radioimmunoassay as well as with
the rat diaphragm assay, we wanted to quantitate the effect or
..

amount of IRI l !berated which is due to heparin.
was performed with the radio immunoassay.

This quantitation

Table XVI and Figure 10

show the results of the radioimmunoassay of IPC without any additions.
Figure 11 and Table XVII show the results of the preincubation of
IPC with 100

g/ml of heparin.

change in the slope.

One can easily detect a definite

Figure 12 and Table XVI II show the results of

the preincubation of IPC with tolbutamide (0.037 M), a hypoglycemic
agent.

Here also a marked increase in the slope is observed.

To

determine whether or not the effect of heparin and tolbutamide is
an artifact, due to an alteration of the immunoreaction, a series
of insulin standards were run in the presence and absence of he~arin
and tolbutamide.

Heparin showed no effect on the radioimmunoassay

using crystalline bovine insulin.
reported similar findings.

Feldman et al. .in 1973 (147)

Tolbutamide, on the other hand, showed

an enhancement of the radio immunoassay with crystalline bovine insulin.

These results, then, demonstrate that while the activation

of IPC by heparin is, in fact, a true activation, the effect of
tolbutamide may be an artifact due to an interference of the immunoreaction between the insulin and the insulin antiserum,

The.finding

in this laboratory with tolbutamide shows that the earlier report on
the same subject by Hasselblatt (148), namely that tolbutamide alters
the radioimmunoassay in such a way that the antibody-antigen reaction

86
TAB LE XV I
RADIO IMMUNOASSAY OF INSULIN PROTEIN COMPLEX
NO ''ACTIVATOR" ARE ADDED.
I PC
mg

CPM-:-S.E.M.

Co/Cl

5

5

5414.:. 85

1• 139

5

10

5140 .:. 31

1. 200

5

20

4852 + 52

1.272

5

30

4173.:. 90

.}. 479

5

40

3877 .:. 40

1. 592

5

50

3538 .:. 49

.1. 744

5

0

6171 .:,113

1. 000

Test
l'JO. ;'~

i'\.

Test was run three .ti mes.

'"

Figure 10. - The graph wai obtained when purified human insulinprotein complex was assayed with the radioimmunoassay, and plotted
according to the technique of Hales and Randle.

The distinct

slope indicates the presence of immuno-reactable insulin (IRI).
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TAB LE XVI I
RADIOIMMUNOASSAY OF INSULIN-PROTEIN COMPLEX.
IPC WAS PREINCUBATED AT 33°C WITH lOO·µg OF HEPARIN FOR 30 MINUTES.

IPC
mg

Heparin
µg

CPM + S.E.M.

C0 /Cl

5

5

100

4652 + 29

l .326

5

. 10

100

4395 !. 22

1 .404

5

20

100

4148 + 56

l.487

5

30

100

3505 !. 44

l • 76 l

5

40

100

3260 + 33

l.893

5

50

100

2968· !. 31

2.079

5

0

100

6171 + 113

1.000

5

0

0

6170 + 101

l. 000

Test
No.~·~

~·~The

test was run 3 times.
TABLE XVIII
RADIOIMMUNOASSAY OF INSULIN-PROTEIN COMPLEX.

THE IPC WAiS PREINCUBATED AT 37°C WITH 100 mg OF TOLBUTAMIDE FOR 30 MINUTES.
I

Test
No.-;',

IPC
mg

Tolbutamide
mg

CPM + S.E.M.

Co/Cl

5

5

1.0

5359 ± 70

l • 15 l

5

10

l.O

5150 ± 31

l • 198

5

20

l.O

.4932 ± 67

l • 25 l

5

30

l. 0

3926 ± 94

l.572

5

40

1.0

3753 ±_, 31

l. 644

5

50

l.0

3205 ± 49

l.926

5

0

l.O

6171 ± 79

1. 553

5

0

0

3973 ± 101

1 .000

I

·f:

The test was run 3 t im"es.

Figure 11. - A Randle and Hale plot (radioimmunoassay) of
human insulin-protein complex when the IPC was preincubated for
30 minutes at 37°C wi.th 100 µg of heparin prior to the radioimmunoassay.

Figure 12. - A Randle and Hale ~lot (ra~ioimmunoass~y) on
human JPC which was preincubated with l mg of tolbutamide
for 30 minutes at 37°C prior to the radioimmunoassay.
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is inhibited, and therefore an apparent enhancement of the action of
tolbutamide on IPC may very well be an artifact.
The effect of IPC on the insulin radioimmunoassay.
The possibility existed that, in the IPC which was isolated,
there might be some substance which interfered with the radioimmunoassay.

To assess the .likelihood of such a possibility, we carried

out the following experiment.

To a known amount of IPC, we added

20, 50 and 100 µU of crystalline bovine insulin and then
mixtures using the radioimmunoassay.
periment was the foHowing:

ass~yed

the

The rationale behind this ex-

if an interfering substance were pre-

sent in the IPC preparation it would interfere with the radioimmunoassay.

The resulting increment in. insulin activity due to the added

pure insulin over the endogenous IPC activity should not be stoichiometric.

If we should obtain results. showing a stoichiometric .incre-

ment in insultn activity, precisely related to the amount oP pure
insulin added, then we could, with confidence, say that in IPC there
are no substances which interfere with the radioimmunoassay.
14 and Table XIX a, b,

Figure

in fact, show a stoichiometric increment in

insulin activity precisely related to the amount of insulin added.
From these data, we conclude that the radioimmunoassay is not interfered with by any substance in the IPC, and, therefore, the·insul in activity exhibited by IPC, using the radioimmunoassay, is true
immunologically active insulin.

TAB LE Xi Xa
RADIOIMMUNOASSAY - INTERFERENC.E STUDY
OF IPC ON THE RADIOIMMUNOASSAY
Test
No.

I nsu 1in
µU

2

20
20
20

3

2
3

2
3

2
3

2
3

2
3
·1

!PC

CPM

Co/Cl

C /Cl ± S.E.M.

5319
5230

1. 194
1.215
1. 191

1.200 ± 0.035

1 .526
l .688
1.638

'1.617 ± 0.045

2.093
1 .979
2.026

2.032 ± 0.032

1 . 435 ± 0 . 09 8

mg

.,,.
I

-

5337
4162

50
50
50

3764
3879

100
100
100

3057
3211
3137

0

.

30
30
30.

4691
4111
4517

l. 354
1.545
l. 407

18
18
18

5340
5102
5117

1 .190
l. 245
1. 241

1.225 ± 0.018

12
12
12

5439
5311

l. 168

l . 192 ± 0·.012

5239

2

6292
6378

3

6397

l . 196
l . 213
6355 ± 29

92a
TABLE XIXb
• >

RADIOIMMUNOASSAY - INTERFERENCE STUDY
OF I Pc' ON THE RADIO IMMUNOASSAY
Rat
No.

I nsu Ii n
µU

IPC

CPM ± S.E.M.

Co/Cl

mg

1-3

20

12

4388 ± 35

1.448

3-6

. 50

12

3318 ± 56

1 . 915

6-9

100

12

2408 ± 27

2.039

9-12

20

18

4211 ± 22

1.509

12-15

50

18

3093 ± 31

2.054

15-18,

100

18

2326 ± 26

2.731

21-24

20

30

4024 ±

6Lt

I .579

24-27

50

30

2673 ± 15

2.377

29-30

100

30

2062 ± 21

3.051

.

\

,,....______r

Figure 14. - This graph shows the result of the study of
whet~er

or not the isolated IPC will influence the radloimmunoassay.

The solid triangle shows IPC activity when measured with the immunoassay.

The open circle

bovine insulin.

broke~

line shows the activity of crystalline

The open line with the open triangle represents

the activity of crystalline insulin of 20 uU, 50 uU and 100 uU to
which 12 mg of IPC was added.

The open line with the open squares

represent the activity of crystal] ine insulin to which 18 mg of
!PC was added.

The open circle solid 1 ine

insulin to which 30 mg of IPC was added.

repre~ents

crystalline
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Binding Studies of Insulin to Lysozyme.
Since the IPC was isolated from a cation exchange resin, one can
assume that the IPC;consists of insulin bound to a basic substance
and that the complex is basic.

Our experiments with heparin could

be interpreted as a competition between heparin, an acidic glycosaminoglycan, and insulin, for the basic protein of the IPC. ·Heparin
could preferentially· bind the basic protein of IPC, resulting in the
liberation of free insulin, which then could be assayed by the radioimmunoassay.
Since, in human plasma, one of the most basic proteins is lysozyme (pl, 10 - 11), we investigated the possibility that lysozyme
might be the basic protein of the IPC.

Determinations of lysozyme

in plasma showed a concentration of 3.2 mg%, using hen egg white
lysozyme as standards (Figure

l~.

Since human lysozyme is four

times as active as hen egg white lysozyme, the concentration of lysozyme in human plasma is, then, 0.8 mg% or 5.9 x 10-

8

M.

Freei

circulating insulin in fasting humans is l x 10- 9 M (page

14).

Figure 16 shows that the peak of IPC from Sephadex C-50 also shows
lysozyme activity.

The question, then, arose of whether or not

lysozyme binds insulin at physiological pH and salt concentrations.
.
l.1n ( 150 µU) was mixed with an
To answer this question, 1251 -1nsu
excess of lysozyme. (5 mg, in O. 15 M NaCl
(pH 7. 4) .

-

0.01 M sodium phosphate

The mixture was chromatographed on a Sephadex G-50 column

Figure 15. - The graph shows a typical standard curve of lysozyme
when assayed with the radial diffusion agar technique.
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equ i 1 i brated and e 1uted with the same buffer.
elution pattern.

Figure· 17 shows the

The first peak, at the void volume, represents al-

.
1.1n as a sta b.11.1zer.
. wh.1c h was present .1n t he 125 1-1nsu
bum1n
small amount of radioactivity is present in this peak.

The

The second

peak showed most of the radioactivity as well as lysozyme.

This

indicates that a complex between lysozyme and insulin was formed,
since lysozyme alone would be retarded more and e.lute in the position
of the third peak.
We have shown that insulin bJnds to lysozyme in vitro and that,
furthermore, during the isolation of IPC on Sephadex C-50, lysozyme
activity appears in the PIG peak.

The presence of lysozyme in the

IPC peak can be the result of three possible phenomena, 1) lysozyme
and insulin are both present in plasma as separate molecules, and
d~ring the isolation procedure, lys6zyme binds to the Sephadex and

then insulin binds to lysozyme, resulting in the formation of a
lysozyme-insulin complex; 2) lysozyme and insulin in plasma form a
.complex and lysozyme is the basic protein of the IPC; and 3) lysozyme and IPC elute from Sephadex C-50 at the same place because of
similar charge characteristics.
To determine whether or not the lysozyme and insulin form a
complex on the column during the isolation procedure, a Sephadex
c-50 column was loaded with lysozyme.

125

on the column and eluted with O. 15 M NaCl.

1-insulin was, then, placed
Figure 18 shows that the

Figure 16, - This figure shows the assay for lysozyme of peak 4
obtained with human serum when chromatographed with Sephadex
C-50.

Tubes

100~122

which showed insulin-like activity, also

revealed high concentrations of lysozyme as can be seen on the
lysis of the attached photography strip.
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radioactivity was eluted with NaCl and recovered quantitatively.
No lysozyme was eluted indicating that a lysozyme-insul in complex
was not formed on

t~e

column.

To investigate whether or not lysozyme is the basic substance
which binds insulin in plasma, resulting in the formation of IPC,
we ran a radioimmunoassay on crystal line insulin in the presence
'
of various concentrations
of lysozyme.

periment is as follows:

The rationale of this ex-

the IPC we isolated shows very little

activity when assayed by radioimmunoassay,
tivated by heparin.

unless it is first ac-

If lysozyme added to insulin (resulting in the

formation of an insul in-lysozyme complex) would decrease the amount
of insulin activity assayed by the radioimmunoassay, we could conelude that lysozyme may be a part of the IPC.
observed, it

~ould

If no decrease were

support the idea that lysozyme and IPC co-elute

only by coincidence.
Figure 19 - 22 and Table XX
the radioimmunoassay in any way.

show that lysozyme does not affect
These data show that lysozyme is

not part of the IPC and that their cg-elution is coincidental and
due only to their similar charge characteristics.
Comparative Study to Isolate IPC from Different Animals.
The attempt to isolate the insulin-protein complex from serum
of dogs, horses, calves and chicken was unsuccessful.
the isolation procedure outlined in

11

In all cases

Materials and Methods 11 was

Figure 17. - El~tion profile of
on. Sephadex G-50.

125

1~insulin-lysozyme complex

The broken curve represents radioactivity;

the solid line the protein peaks.

For description of experiment

see text.
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TABLE XX
INFLUENCE OF LYSOZYME ON THE RADIOIMMUNOASSAY.
Insulin
µU

Lysozyme
mg%

CPM +

10
20
50
100
200

S.E.M.~<:

Co/Cl

9495 + 73
8975 + 43
7697 + 90
6582 + 97
5852+118

1 .032
1. 091
1.273
1. 488
1.674

10
20
50
100
200

1•2
1.2
1.2
1.2
1.2

9060 + 68
8556 + 95
8301 + 94
. 7640
134
5406 + 122

1.081
l. 146
1. 180
l. 27.5
l.812

10
20
50
100
200

4.0
4·. 0
4.0
4.0
.. 4 .o

8314 + 139
8518 + 129
7239 + 86
6569 + 90
5818 + 78

1 • 178
l. 150
1.353
1. 491
l. 689

l0
20
50
l 00
200

8.o

8.o
8.0
8.0

9436 + 138
9408 + 186
8295 + 106
6534 + 80
5572 + 93

1. 038
l. 037
1 • 181
l. ~99
1. 758

0
0
0

1.2
4.0
8.o

9825 + 129
9813 + 130
9808 + 142

0.998
0.999
1. 000

0

0

~Values

8.o

were obtained from five duplicates.

+.

9810

!.
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l .000

figure 19. - Radio~mmunoassay. (Randle and Hales plot) of
crystalline bovine insulin.

Figure 20. - Radioimmunoassay (Randle and Hales plot) of
crystalline bovine insulin'when a solution of 1.2 mg% of
lysozyme was added.
..

',

Figure 21. - Radioimmunoassay (Randle and Hales pl?t) of
crystalline bovine insulin when a solution of 4.0 mg% of
lysozyme was added.

Figure 22. - Radioimmunoassay (Randle

an~

Hales plot) of

cry5talline bovine insulin when a solution of 8.0 mg% of
lysozyme was added.
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applied.

Among all animals, the dog was the only animal which showed

traces of IPC, when measured with the radioimmunoassay procedure and
in the presence of heparin.

This ex per i men t would 1ead one to be-

lieve that the insulin-protein complex may be unique to humans.
on other animals would give.a more definite answer.
TABLE XXI
I PC/m 1 serum

Animals

Biotin

Heparin
Human

Dog

2 I !_ 9*

19 + 3

'i)

5+ 2

Horse

0

0

Calf

0

0

Chicken

0

0

'"values were obtained with the radioimmunoassay

r

Tests

TABLE XXI
COMPARATIVE STUDY bF IPC ON blFFERENT ASSAYS
-?

Test
Nos.

Insulin equivalence/ml plasma
I PC
I PC/Biotin
I PC/Heparin
+ S.E.M.;'c
+ S.E.M.
+ S.E.M.

-

/

1.

Radioimmunoassay

7

20 + 10

115::._12

2.

Rat Diaphragm Bioassal

9

15 + 11

203 + 30

21 +

9

320 ::.. 40

3.

*

Rat lntraperitoneal Bioassay

6

260 + 50

Standard error of the mean.

)

'>

0

+:-

..
252 + 28

374 ::.. 63

Figure 23. - A graphic interpretation of Table XX (Bl
on each of the three schemes.

=

IPC)

The first vertical grouping

represents the amount of I PC/ml serum -when assayed without
an ''activator'' with the radioimmunoassay, rat hemi-diaphragm
bioassay and with

the~

vivo rat intraperitoneal bioassay.

The second vertical grouping represents, the IPC values of IPC
when heparin was used as an "activator".

The third vertical

grouping represents biotin when used as an "activator".

The

fourth vertical grouping represents the rat diaphragm and rat
,1

intraperitoneal bioassay when biotin was blocked by avidin.

'.
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CHAPTER IV
1

One of the

~ost

DISCUSSION

intriguing and yet frustrating chapters in

diabetes research involves the study of insul in-1 ike activity in
human plasma and

serum~

The term intriguing seems

~o

describe the

results thus far obtained from various investigators.

On the other

hand, this field is an extremely frustrating one in that despite
')

what appears to be well understood and accepted operational definitions and comparable procedures and techniques the results are often
not uniform and frequently contradictory.
Since the mid 1950s the literature is replete with reports by
various groups all over the world, that there may exist substances
which exhibit insulin-like activity.

The term insulin-like activity

refers to as yet uncharacterized substances which seem to be able
to assist glucose utilization by the muscle and fat cells.

However,

these substances seem to lack characteristics which are unique to
the hormone insulin, namely controlling

e~zyme

mechanisms in car-

bohydrate, protein and lipid metabolism (see lntrod~ction, page 18).
These compounds do· not have the ab i 1 i ty to induce prate in synthesis .
(91) •
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Insulin-like activity has been subdivided into two categories:
a.

insulin-protein complexes, and b.

compounds which have nothing

in common with insulin, as far as molecular structure is concerned

(155). As described in the

11

lntroduc.tion 11 and

11

Results 11 our labora-

tory was interested in reinvestigating the reports which came from
the laboratory of _Antoniades and coworkers (58) and Shaw et al. (70)
that insulin circulates in blood in a free and bound forms.

This

theory has been rejected by Berson et al. (76) and Meade et al. (75)
who have·not been able to demonstrate

11

bound insul in 11 •

In 1964

Froesch (94), in Switzerland, wa~ able t~ isolate an~ later (155)
characterize a compound which· exhibits insulin-like activity.

Since

this finding the hypothesis that insulin could be bound to a basic
protein has been abandoned.
(84) believe that

11

In. fact, Poffenbarger and his colleagues

bound 11 insulin, as described by Antoniades, and

the compound with insulin-like activity elucidated' by Froesch are
one and the same substance.
extent in that he writes:

Froesch agrees with this group to some
11

Purified smal 1 molecular ·weight non-

·suppressible ILA (6,000 to 10,000) was chromatographed on Dowex
and recovered in the alkaline eluate, thus
of

11

bound insulin 11 •

fulfilli~g

the criteria

We believe that this statement is rather con-

fusing, because insulin as a dimer (Zn-insulin) has a MW of 12,000
in the pH range of 7.8 - 8.2 as,• reported by Boyle and Hexmer '(149)
and above'pH 10 insulin exists as a monomer of a MW of 6,000 as reported by Marcker (150) •. It seems reasonabl_e to assume that an insulinp'rotein complex has·to have a

M\~

greater than the MW of insulin itself.
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Furthermore, our hypothesis is that this complex in all probability
I

will not exhibit insulin activity, unless physical or.chemical methods
are applied to dissociate the complex, thus releasing active insulin.
When the procedure of Antoniades and coworkers was applied to
isolate

11

bound 11 insulin, we were not able to reproduce their results,

and thus were faced with two possible alternatives;

either (a)

Antoniades had fallen victim to an artifact of the experimental
procedure he employed, or (b) his separation procedures were too
harsh.

For reasons already described under

11

Results 11 namely, that

the choice of a cation exchange resin, with its very acidic sulfate
groups, and the elution method which creates a pH over l 1, coupled
with the harsh subsequent neutralization method, might have destroyed
whatever insulin-protein complex was present in human plasma 'or
serum, we,decided to reinvestigate the possible presence of a
11

boun<l 11 insulin using much milder conditions.

For this purpose we

used Sephadex C-50, Amberl ite IRC-50 and BioRad Rex 63, since all
three resins have weaker exchange residues than Dowex and, therefore,
minimize the possibility of hydrolysis.of insulin through the acidic
groups or highly alkaline elutants, since a lower pH is required to
elute any insulin-protein complex bound to these resins.
f

The results which we obtained with these resins are shown in
Table XII and the graphical pattern of the elution with ammonium
carbonate in Figure 5.

These·results strongly suggest, that when

the IPC compound was tested for insulin activity with the radioimmunoassay and the hemidiaphragm bioassay, it exhibited

~ctivity,

but

109
only after the IPC had been preincubated with 0. 1 mg/ml of heparin
and 0.01 mg/ml of biotin.
11

activators 11 •

These compounds are designated as

In 1968 Gjedde (151) reported that insulin was bound

to serum globulins and later Cantrell et al. (152) reported the
binding of insulin to immunoglobulins.
to us that indeed

i~sulin

These reports suggested

binds to other serum proteins.

Table XVI demonstrates that with the radioimniunoassay small
amounts of immunoreaciive insulin were picked up without the addition
of

11

activafors 11 •

two experiments.

The validity of this finding was confirmed with
If the values of 20 µU/ml of serum represent

immunoreactive insulin, then we.should be able to obtain a typical
Randle and Hales plot, if increasing amounts of IPC are assayed
with the radioimmunoassay procedure.

The results of th1s experi-

ment are listed.in Table XVI indicating the presence of insulin in
the protein preparation.

The question of whether or' not the slope

was the' result of an alteration of the radioimmunoassay by some
compo~nd

ment.

in the IPC preparation was answered in the secbnd experi-

Constant amounts of purified insulin were added to increasing

amounts of 1ec and then

~~sayed.

· Figure 14, and Table XIXa and b

showed almost an exact additive effe.ct in the change of the slope
'

caused by exogenous insulin.
Havihg performed these experiments, the question arose as to
whether we were dealing with an insulin-protein complex which

·,
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in~~

dissociates to some extent

free insulin and basic protein, or

whether the insulin determined with the radioimmunoassay was an
artifact due to trapped insulin in the resin.

This possibility

seemed unlikely since for these studies peak I I I from Sephadex G-200
was used exclusively.
the IPC

prepar~tion

To eliminate the possibility of an artifact,

was incubated with heparin (0.1 mg/ml).

Heparin

as well as insulin a~e both anionic substances, but since heparin
is much more anionic than insulin, one.can expect that heparin will
bind preferentially to the basic component of IPC, thus releasing
free insulin.
and Figure 11.

The results of this experiment are shown in Table XVI I
Under these conditions, the radioimmunoassay picked

up five times'as much insulin, demonstrating that heparin does, in
fact, release insulin and that insulin is bound to a basic protein
and that furthermore the

11

bound 11 insulin is not immunoreactive.

This experiment did not give any conclusive proof as to the nature
of the insulin-protein complex, but it shows that circulating insulin
is complexed in part to some basic protein.

Heparin also enhanced

,the insulin activity of the IPC. using the .rat hemidiaphragm bioassay.
In this b.ioassay the increased activity was even more pronounced,
approximately 500 per cent enhancement of Iactivity being obtained. .
In 1963, Hasselblatt (148) and in 1970, Przyby·la (146) postulated
an increase of ins.ulin-like activity, when they used the hypoglycemic
drug tolbutamide.
case.

We therefore used this drug to strengthen our

As seen in Figure 12, a definite increase in the slope was
~.
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achieved in comparjson with IPC alone.
proved to be an artifact.

However, this result may have

In fact, when tolbutamide was run with

insulin standards the values were distorted, suggesting that the
effect of tolbutamide resulted from an alteration of the insulinantibody reaction and had no effect on the IPC. ,Similar studies
with heparin

showe~

that it has no influence on the immunoreaction

and that its effect was the result of the liberation of insulin from
the IPC.

This findrng was confirmed by Feldman in 1973 (147).

The 'finding of Coggeshall in 1968 (153) that biotin plays a
role in carbohydrate metabolism other than co
test biotin on the isolated IPC compound.

2

fixation led us to

Biotin in physiological

concentration (0.01 mg/ml) was incubated for 30 minutes, as was
heparin, with a specific amount ·of 0IPC.

The preparation was then

assayed for insulin activity with the radioimmunoassay and the rat
hemidiaphragm .bioassay.
surprising indeed.

The result.s of this experiment were very

The immunoassay showed absolutely no activity;

howe.ver, the diaphragm responded significantly.
~btained

with biotin with the

bioass~y

The insulin activity

was severely decreased when

avid in, an .inhibitor for biotiri, was used,
Since biotin alone failed to show any insulin activity using
'
the rat hemidiaphragm bioassay, in collaboration with Crolla (156)
1n our laboratory, we performed deuterium exchange and circular
dichroism ~tudies on the IPC compound, with the addition of bi6tin.
We clearly showed conformational changes of the IPC by both methods.
T~is

finding suggested to us that through a change iri the 3-dimensional

112

structure of the IPC compound, insulin regains its biological activity.

These results also suggested that IPC may not have to be dis-

sociated to obtain insulin activity.

These results led us to per-

--

.

form an in vivo experiment {intraperitoneal bioassay) to determine
whether or not the IPC is involved in the transport of glucose
across the cell membrane of muscle.

The results of these experiments,

summarized in Table XX, show that the IPC can be activated by the
intact animal and that the addition of biotin and heparin did not
·.result in any large augmentation of activity, indicating perhaps
that the conplexed insulin is a normal phenomenon and not the result
of pathological conditions in wl1ich the animal or human is deprived
of biologically active insulin.
1:1as

v1~1ether

The next question we investigated

IPC is a unique feature of humans or it is also present

in other animals.

Thus, vie attempted to isolate the IPC from sera

of calves, horses, dogs, and chickens.

.Je \·1ere not ab·le to demonstrate

1

any appreciable amounts in the sera of these animals.
In summary, ;-1e have demonstrated that with mild isolation methods
an insulin-protein complex can be isolated from human serum v1hich is
inactive v1hen assayed with

an~

vitro insulin assay and that the

complex can be activated by heparin and biotin.

These two substances,

however, activate the IPC through different mechanisms.

Heparin binds

to the basic component of the iPC liberating free insulin, whereas
biotin causes a change in the 3-dimensional structure of IPC resulting
in the IPC acting as insulin itself.

Biotin somehow exposes the in-

sulin moiety of the IPC so that it becomes biologically active but
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immunologically inactive.

We also disproved earlier reports that

tolbutamide plays a role in activating the IPC compound.
more, we showed that

pos~ibly

Further-

only in human serum or plasma, is

insulin carried and made inactive by a basic protein.
As shown in the

11

Results 11 , five peaks were obtained when IPC

was chromatographed on Sephadex G-200.
detected only in peak I I and I I I.

lnsul in-1 ike activity was

Molecular weight estimation

with gel filtration revealed ttW of 158,000 and 102,000 for peak II
·and I I I respectively.

Both peaks, when electrophoresed on cellu-

lose acetate, showed strong bands in the beta globulin fraction;
both peaks were devoid of albumin and gamma globulin bands.

Since

peak I I did not show any insulin activity when measured with the
radio immunoassay, we believe that this protein fraction represents
the ILA compound, which has been isolated and characterized by
Froesch and coworkers (94).
~1hen

Peak I I I, however, showed activity

it 1-1as preincubated v1ith heparin and assayed v1ith the radio-

immunoassay.

This may confirm Frocsch's observations that in plasma

there exists a high molecuL:ir \·<eight substance (!LA) that exhibits
insulin-I ike activity; furthermore it demonstrates the presence in
human plasma of a bound form of insulin (IPC).
We also investigated the possibility that lysozyme could be
the basic protein which binds insulin in plasma to form the inactive
IPC.

However, we were unable to show that lysozyme is part of the

IPC, even though insulin and lysozyme form complexes in vitro (159).
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Whether the comp 1exed fo_rm of i nsu 1 in is a norma 1. mechanism
for insulin preservation or is a biological deactivatlon of physiologrcal active ins.Lil in is unknown.

Antoniades 1 report (69) that

bound insulin seems to increase in some diabetic patients points
to the latter possibility; however, this observation has not been
.confirmed~

The question of why bound insulin has not been con-

sistently demonstrated in plasma remains unanswered.

One explana-

tion could be that biotin and heparin, in the concentration used
in our experiments, do not represent the concentration which the
cells require to activate the insulin-protein complex.
the function of IPC7
of

11

One can only speculate.

\4hat is

It could be a sort

delayed 11 mechanism of insulin action - a sort of built in

buffertng system.
~-insulin

Gerritzen has described (154) the use of Jelaying

action using insulin derivatives.

The human body may have

adopted such a delaying system in the form of an insulin-protein
complex, long before synthesized insulin derivatives were used.

CHAPTER V
SUMMARY AND CONCLUSION
In 1958, Antaniades (S8) described the presence of an insulinprotein complex (IPC) in human serum.

In the intervening years,

a number of investigators have tried to isolate the IPC using
Antoniades 1 methods, but wrthout success.

Many investigators, on

tbe basis of the work of Froesch,'have thought that Antoniades
had actually isolated a high molecular weight substance with insulin activity, as in the work by Froesch.
1

-In this investigation, using milder procedures, we have been
able to isolate, from human serum, an IPC, with a MW of 100,000,
which exhibits almost no insulin

a~tivity

with -in vitro assay
.

methods, such as the rat hemi-diaphragm bioassay or the radioimmunoassay.
assayed with

However, the complex shows insulin activity when

.!..!!. ~ assays.,_ such as the i ntraper i tonea 1 bi oassay.

The !PC can be activated in vitro by incubation with heparin and
biotin, but possibly not with Tolbutamide, contrary to what has
been reported in the literature (148).
hibits insulin activity with

~·vitro

The

11

activated 11 IPC ex-

bioassays.

The mode of

activation of the IPC by heparin is apparently due to the dissociation
115

116

of insulin from the complex, .whereas the activation by biotin appears
to be due to a conformational change in the 3-dimensional structure
of complexed insulin:
Since lysozyme forms complexes with insulin in vitro, we thought
that lysozyme may have been the basic protein of the IPC.
we demonstrated that lysozyme is not part of the IPC.

However,

We also

attempted to isolate the IPC from sera of calves, horses, dogs and
chickens.
of IPC.

In none of these sera were we able to show the presence
Thi.s would seem to indicate that an IPC may be characteristic:

of humans alone.
Speculations as to the function of IPC are difficult at the
present, because it is not ·known whether IPC fluctuates under conditions· of aberrant glucose metabolism.
r~which.

to

It may be a form of insulin

is activated under physiological stress or it may be a mechanism

inactiv~te

and conserve insulin.

lf speculationscare difficult,

we can say with confidence that the argument as to the existence
or non-existence of an lPC in normal human serum can be put to rest.
We have definetly proven that it.exists.
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